Other strabismus

H7_STRABOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H50 Cause of death: ICD-10 — H50 2 out of 7 registries used, show all original rules.	6819
4. Check minimum number of events None	6819
5. Include endpoints H7_CONVERSTRAB H7_DIVERGSTRAB H7_VERTISTRAB H7_INTERHETEROTRO H7_HETEROTRONAS H7_HETEROPHORIA H7_STRABMECH H7_STRABNAS	10685
6. Filter based on genotype QC (FinnGen only)	10322

Control definitions (FinnGen only)

Control exclude: H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H49-H52
Name in latin: Alius strabismus

NAME	H7_STRABOTH
CONTROL_EXCLUDE	H7_OCUMUSCLE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_CONVERSTRAB\|H7_DIVERGSTRAB\|H7_VERTISTRAB\|H7_INTERHETEROTRO\|H7_HETEROTRONAS\|H7_HETEROPHORIA\|H7_STRABMECH\|H7_STRABNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H50
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H50
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other strabismus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	120913	66402	54258
Only index persons	99190	55293	43897
Unadjusted period prevalence (%)
Whole population	1.73	1.90	1.52
Only index persons	1.87	2.03	1.68
Median age at first event (years)
Whole population	7.68	8.28	6.82
Only index persons	9.48	10.67	7.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10322	6753	3569
Unadjusted period prevalence (%)	2.13	2.40	1.64
Median age at first event (years)	24.01	21.80	28.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10684: Matched controls
106440

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

319.0

2318

10290

3503

FHL

Single muscle retroposition

8524.2

307.7

803

H50.52

ICD-10 Finland

Exophoria

298.4

307.7

1918

H50.9

ICD-10 Finland

Strabismus, unspecified

93.4

307.7

336

H50.30

ICD-10 Finland

Intermittent esotropy

929.7

307.7

780

H50.2

ICD-10 Finland

Vertical strabismus

495.0

307.7

1073

H50.1

ICD-10 Finland

Divergent concomitant strabismus

1586.3

307.7

1258

H52.1

ICD-10 Finland

Myopia

6.7

307.7

537

840

H50.51

ICD-10 Finland

Esophoria

218.3

307.7

600

37301

ICD-8 Finland

Strabismus, Concomitans divergens

+∞

307.7

1664

H50.31

ICD-10 Finland

Intermittent exotropia

2100.8

307.7

1552

H52.0

ICD-10 Finland

Hypermetropia

15.9

307.7

484

317

CEC00

NOMESCO Finland

Recession of extraocular muscle

6584.8

307.7

633

3507

FHL

Retroposition and resection

1916.8

307.7

391

H50.0

ICD-10 Finland

Convergent concomitant strabismus

2215.9

307.7

1251

H53.0

ICD-10 Finland

Amblyopia ex anopsia

21.9

307.7

439

208

H53.2

ICD-10 Finland

Diplopia

14.8

307.7

1165

873

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.6

307.7

1527

4766

37300

ICD-8 Finland

Strabismus, Concomitans convergens

+∞

307.7

1068

3782B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]

+∞

307.7

315

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

6113.0

307.7

1123

37303

ICD-8 Finland

Strabismus, Heterophoria (exophoria, esophroria, hypophoria)

+∞

307.7

732

3781B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]

+∞

300.0

287

H52.2

ICD-10 Finland

Astigmatism

10.4

280.8

314

308

3781A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]

+∞

259.0

248

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

+∞

244.4

234

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

18.7

236.5

188

102

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

1117.8

225.4

220

CEC30

NOMESCO Finland

Resection of extraocular muscle

+∞

223.4

214

H50.8

ICD-10 Finland

Other specified strabismus

290.5

223.0

227

H50.59

ICD-10 Finland

Heterophor UNS

84.9

222.6

118

3505

FHL

Single muscle resection

+∞

205.6

197

H50.50

ICD-10 Finland

Alternating hyperphoria

58.8

197.9

111

3780B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]

+∞

196.2

188

3784B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]

+∞

188.8

181

37302

ICD-8 Finland

Strabismus, Concomitans sursum sive deorsum vergens

+∞

185.7

178

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

+∞

181.5

174

F95

ICPC

Strabismus

51.8

179.2

103

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

11.6

162.8

168

146

XCK00

NOMESCO Finland

Perimetry

3.1

162.5

710

2365

CEW99

NOMESCO Finland

Other operation on extraocular muscle

1627.9

160.5

156

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

520.3

155.9

155

H51.1

ICD-10 Finland

Convergence insufficiency and excess

381.5

151.3

152

3504

FHL

Retroposition of two muscles

1505.8

150.1

146

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

170.7

144.7

152

CE2W4

NOMESCO Finland

Eye movement mapping

34.8

142.3

H53.3

ICD-10 Finland

Other disorders of binocular vision

12.1

136.5

137

114

H50.4

ICD-10 Finland

Other and unspecified heterotropia

638.6

128.5

127

WX140

NOMESCO Finland

Parabulbar anesthesy

3.3

125.9

486

1499

3783A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia

+∞

124.0

119

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

124.0

3905

27528

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

122.4

1001

4551

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

12.4

114.1

113

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

100.5

777

3438

H50.6

ICD-10 Finland

Mechanical strabismus

+∞

99.0

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.3

98.7

145

200

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

95.7

2836

19419

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

11.7

89.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

86.7

970

4963

AA1AD

NOMESCO Finland

CT of head and brain

1.6

86.7

2233

14710

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

78.3

963

5089

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

78.2

828

4147

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

+∞

77.1

CEC20

NOMESCO Finland

Recession and advancement of extraocular muscle

+∞

76.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

75.9

867

4461

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

9.6

75.0

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

7.9

74.9

102

129

H52.5

ICD-10 Finland

Disorders of accommodation

26.9

74.2

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

17.7

73.7

P85

ICPC

Mental retardation

9.5

71.8

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

348.3

69.6

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

68.9

357

1301

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

66.7

1107

6426

N03AX09

ATC

lamotrigine; oral

2.2

65.4

605

2873

CEC50

NOMESCO Finland

Advancement of extraocular muscle

+∞

64.5

H50.3

ICD-10 Finland

Intermittent heterotropia

+∞

64.5

37309

ICD-8 Finland

Strabismus, Unspecified

+∞

64.5

ZXA10

NOMESCO Finland

Bilateral

1.6

64.2

1605

10409

N03AG01

ATC

valproic acid; systemic, rectal

2.1

62.0

625

3066

F83

ICD-10 Finland

Mixed specific developmental disorders

4.6

60.9

147

325

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

58.7

474

2129

H50

ICD-10 Finland

Other strabismus

297.7

58.2

N03AX12

ATC

[U] gabapentin; oral

1.6

56.0

1427

9271

ZXA00

NOMESCO Finland

Right side

1.5

55.6

2099

14889

Z3231

NOMESCO Finland

Registered nurse

1.5

55.5

2528

18616

N05AH04

ATC

quetiapine; oral

1.5

55.4

1810

12453

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

55.2

522

2498

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

55.0

2382

17365

R42

ICD-10 Finland

Dizziness and giddiness

1.5

55.0

1915

13353

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

55.0

680

3587

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

145.2

54.8

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

13.0

54.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

54.1

3121

23984

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

53.3

1142

7098

R51.80

ICD-10 Finland

Headache

1.5

53.2

1664

11327

R62.0

ICD-10 Finland

Delayed milestone

4.3

53.0

136

316

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

53.0

1873

13091

N06AX11

ATC

mirtazapine; oral

1.4

52.2

3105

23959

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

+∞

52.0

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

11.3

50.6

3782A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS CONVERGENS INTERMITTENS]

+∞

50.0

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

49.9

740

4137

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

48.4

533

2699

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.8

47.9

805

4673

H50.39

ICD-10 Finland

Intermittent heterotropia

166.8

47.8

H05.2

ICD-10 Finland

Exophthalmic conditions

10.0

47.5

ZXA05

NOMESCO Finland

Left side

1.5

47.1

1918

13760

3508

FHL

Transposition or anteposition

+∞

46.8

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

46.6

551

2860

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.5

46.5

308

1267

TAB00

NOMESCO Finland

Lumbar puncture

2.1

45.3

454

2220

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

11.2

44.6

N03AX16

ATC

[U] pregabalin

1.5

44.6

1919

13898

N05AH03

ATC

olanzapine; systemic

1.8

44.4

641

3552

H26.4

ICD-10 Finland

After-cataract

1.8

43.8

634

3516

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.7

43.7

102

220

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

43.5

2326

17514

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

15.2

43.2

183

Kela drug reimbursment

Lamotrigin and topiramate

3.7

42.9

136

369

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

+∞

42.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

42.4

1817

13135

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

42.1

940

5887

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

41.8

1533

10743

N06AX16

ATC

venlafaxine; oral

1.5

41.1

1392

9597

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

40.8

683

3956

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

40.7

3671

29977

N07AA02

ATC

pyridostigmine; systemic

6.0

40.6

118

37002

ICD-8 Finland

Refractive errors, Myopia

+∞

40.6

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

40.4

982

6279

CS494

NOMESCO Finland

Other visual field testing

2.7

39.9

221

834

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

39.8

312

1383

N05BA09

ATC

clobazam; oral

4.2

39.6

106

255

N03AX11

ATC

topiramate; oral

2.4

39.2

283

1211

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

38.8

783

4774

Z2445

NOMESCO Finland

Psychologist

1.9

38.6

483

2553

3510

FHL

Cardiac surgery on three or more muscles

+∞

38.5

R06.0

ICD-10 Finland

Dyspnoea

1.4

38.4

2141

16189

H52.4

ICD-10 Finland

Presbyopia

2.5

38.3

249

1016

3519

FHL

Other measure in this category

+∞

37.5

N06AX21

ATC

duloxetine; oral

1.6

37.4

1068

7084

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

37.0

220

861

H02.4

ICD-10 Finland

Ptosis of eyelid

2.5

36.9

237

962

H27.0

ICD-10 Finland

Aphakia

7.9

36.8

N05CF01

ATC

zopiclone; oral

1.4

36.7

2521

19699

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.9

36.6

ZXE00

NOMESCO Finland

One hour or less

1.3

36.5

3507

28776

3781X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALIUS]

+∞

36.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

36.3

2317

17886

G70.0

ICD-10 Finland

Myasthenia gravis

6.8

36.2

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

35.9

1973

14858

R03AC02

ATC

salbutamol; inhalant

1.3

35.8

5323

46258

G47.3

ICD-10 Finland

Sleep apnoea

1.4

35.5

1789

13275

H50.5

ICD-10 Finland

Heterophoria

+∞

35.4

WX402

NOMESCO Finland

General anaesthesia

1.4

35.3

1921

14442

RL140, ,

NOMESCO Finland

7.3

34.9

H47.2

ICD-10 Finland

Optic atrophy

6.0

34.7

102

37929

ICD-8 Finland

Blindness, one eye, specifically defined

46.6

34.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

34.3

1329

9387

CEC40

NOMESCO Finland

Resection and advancement of extraocular muscle

+∞

34.3

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.3

34.3

266

1174

H03AA01

ATC

levothyroxine sodium; systemic

1.4

34.3

1961

14854

WX002

NOMESCO Finland

Sedation and analgesia

1.4

34.3

1500

10844

N02BE01

ATC

paracetamol; systemic, rectal

1.4

34.2

8622

80193

H54.5

ICD-10 Finland

Severe visual impairment, monocular

5.3

34.2

128

G91.1

ICD-10 Finland

Obstructive hydrocephalus

6.3

34.0

N05AX12

ATC

aripiprazole; systemic

1.9

33.8

452

2443

N05BA01

ATC

diazepam; systemic, rectal

1.5

33.7

1037

6985

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

7.0

33.7

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

10.9

33.6

N02AX02

ATC

tramadol; systemic, rectal

1.3

33.4

3484

28825

H062, E050,

ICD-10 Finland

9.5

33.1

SPAT1301

SPAT

No procedures

1.3

33.0

2736

21925

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

33.0

357

1796

N03AE01

ATC

clonazepam; systemic

1.8

32.9

481

2672

N03AX14

ATC

levetiracetam; systemic

2.3

32.9

260

1157

F82

ICD-10 Finland

Specific developmental disorder of motor function

4.1

32.9

216

F05

ICPC

Visual disturbance other

2.2

32.3

277

1276

3501

FHL

Myotomy or tenotomy

+∞

32.3

108

Kela drug reimbursment

Myasthenia gravis

7.9

32.2

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

32.1

472

2628

G04BD12

ATC

mirabegron; oral

1.6

32.0

785

5023

N06AB04

ATC

citalopram; systemic

1.4

31.9

1743

13089

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

4.3

31.8

192

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

31.7

2021

15554

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

31.5

518

2981

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

31.4

677

4193

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

7.0

31.1

M03BX01

ATC

baclofen; systemic

2.6

31.1

181

701

C07AA05

ATC

propranolol; systemic

1.4

30.7

1875

14324

N06AB06

ATC

sertraline; oral

1.5

30.7

1099

7635

H57.1

ICD-10 Finland

Ocular pain

2.0

30.7

364

1891

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

30.5

7165

65277

N04BC05

ATC

pramipexole; oral

1.7

30.3

558

3317

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

30.2

305

1496

UKC02

NOMESCO Finland

Cystoscopy

1.5

30.2

1020

7003

G44.2

ICD-10 Finland

Tension-type headache

1.4

30.1

1271

9110

S06.0

ICD-10 Finland

Concussion

1.5

30.0

979

6671

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

30.0

403

2182

SPAT1312

SPAT

General health counselling

1.3

29.9

3075

25302

N03AF02

ATC

oxcarbazepine; oral

2.0

29.9

310

1536

R53

ICD-10 Finland

Malaise and fatigue

1.3

29.7

2117

16551

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

29.7

669

4191

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

29.6

642

3982

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

29.6

2412

19227

H02AB06

ATC

prednisolone; systemic

1.3

29.5

4052

34558

N06AA09

ATC

amitriptyline; systemic

1.6

29.4

696

4412

H26.02

ICD-10 Finland

Presenil cataract

2.3

29.1

211

906

ZXD20

NOMESCO Finland

Day surgery

1.5

29.0

1061

7399

SPAT1263

SPAT

Sampling

1.3

28.7

3887

33063

L17

ICPC

Foot/toe symptom/complaint

1.3

28.7

2467

19797

SPAT1240

SPAT

Therapeutic discussion

1.5

28.7

1125

7950

H53.4

ICD-10 Finland

Visual field defects

2.6

28.6

167

648

XCW11

NOMESCO Finland

Assessment of strabismus

149.9

28.6

N05AX08

ATC

risperidone; systemic

1.6

28.5

644

4036

S18

ICPC

Laceration/cut

1.3

28.4

3771

31990

M79.6

ICD-10 Finland

Pain in limb

1.3

28.3

3712

31437

Q12.0

ICD-10 Finland

Congenital cataract

11.1

28.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

28.2

716

4615

37000

ICD-8 Finland

Refractive errors, Astigmatismus

+∞

28.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

28.0

1266

9183

SPAT1310

SPAT

Counselling related to known health issue

1.3

27.5

2857

23489

A06AD11

ATC

lactulose; oral

1.5

27.3

967

6696

N05AH02

ATC

clozapine; systemic

2.4

27.0

193

824

SPAT1260

SPAT

Consultation of another employee

1.4

26.8

1470

11014

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

26.8

185

778

A02BC02

ATC

pantoprazole; systemic

1.2

26.7

5871

52625

XKD00

NOMESCO Finland

Uroflowmetry

1.5

26.7

891

6097

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

96.6

26.6

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

26.5

637

4052

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

26.4

499

2987

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

26.1

440

2552

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

26.1

622

3950

37304

ICD-8 Finland

Strabismus, paralyticus. Paresis nervorum III, IV, VI

+∞

26.0

WX704

NOMESCO Finland

Intubation

1.6

25.9

665

4295

602

Kela drug reimbursment

Children's severe malnutrition

3.8

25.7

206

H54.7

ICD-10 Finland

Unspecified visual loss

3.8

25.7

202

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

25.6

733

4854

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.8

25.6

128

460

XKC03

NOMESCO Finland

Water cystometry

2.1

25.5

229

1075

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

25.4

3154

26449

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

25.3

1488

11265

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

25.3

756

5050

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

25.2

1129

8170

N04AA02

ATC

biperiden; systemic

2.4

25.1

168

696

A28

ICPC

Limited function/disability NOS

1.4

25.1

1034

7365

SPAT1229

SPAT

Assessment of need for aid

1.7

25.1

502

3049

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

25.0

2787

23059

N17

ICPC

Vertigo/dizziness

1.5

25.0

937

6557

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.9

25.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

25.0

1124

8138

A02BC03

ATC

lansoprazole; oral

1.3

24.8

2129

17032

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

24.7

862

5950

H03BB01

ATC

carbimazole; oral

1.8

24.5

340

1859

L28

ICPC

Limited function/disability (L)

1.4

24.3

1179

8646

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

24.3

207

952

3784A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[ESOPHORIA]

+∞

23.9

3671A

ICD-9 Finland

Disorders of refraction and accommodation, Myopia

+∞

23.9

37003

ICD-8 Finland

Refractive errors, Anisometropia

+∞

23.9

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.1

23.8

217

1025

N06AB10

ATC

escitalopram; oral

1.3

23.8

1983

15789

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

23.7

5191

46238

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

8.6

23.5

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

23.2

113

400

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.3

23.2

179

791

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.1

23.1

230

1124

CGD10

NOMESCO Finland

Laser keratoplasty for error of refraction

8.3

23.0

M54.5

ICD-10 Finland

Low back pain

1.3

23.0

3194

27070

Z2446

NOMESCO Finland

Social worker

1.6

22.9

616

4020

E0000UV, ,

ATC

1.2

22.9

3849

33304

G20

ICD-10 Finland

Parkinson disease

2.2

22.8

189

860

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

5.2

22.8

N06AB03

ATC

fluoxetine; oral

1.4

22.6

1035

7511

J01DB01

ATC

cefalexin; oral

1.3

22.6

8127

76134

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.9

22.5

100

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

22.5

422

2521

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

6.5

22.4

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

22.4

225

1104

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

22.3

2372

19468

SPAT1153

SPAT

Removal of sutures

1.3

22.3

2384

19581

N05BA04

ATC

oxazepam; oral

1.3

22.2

2156

17492

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

22.2

783

5414

A04

ICPC

Weakness/tiredness general

1.4

21.9

1289

9745

R11

ICD-10 Finland

Nausea and vomiting

1.5

21.9

758

5219

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

21.9

1211

9068

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

21.8

1555

12101

A02BC05

ATC

esomeprazole; systemic

1.2

21.5

3307

28288

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

21.5

1046

7666

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

21.5

402

2399

M41.4

ICD-10 Finland

Neuromuscular scoliosis

7.1

21.5

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

21.5

7267

67360

N03AF01

ATC

carbamazepine; oral, rectal

1.8

21.5

351

2018

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

21.4

2072

16800

L03

ICPC

Low back symptom/complaint

1.3

21.3

2430

20097

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.3

21.2

160

700

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

21.2

591

3887

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

21.2

3561

30737

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

21.2

419

2538

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

21.2

380

2243

UDC00

NOMESCO Finland

Ear microscopy

1.5

21.1

604

3998

N06AX26

ATC

vortioxetine; oral

1.5

21.1

688

4682

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

21.0

3384

29077

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

21.0

1111

8257

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

21.0

1692

13387

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

20.9

438

2693

SPAT1216

SPAT

Assessment of functional ability

1.4

20.9

1017

7456

3670A

ICD-9 Finland

Disorders of refraction and accommodation, Hypermetropia

+∞

20.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

20.7

3872

33780

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

20.6

1118

8342

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

20.6

1123

8386

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

20.5

412

2506

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

20.4

998

7317

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.5

20.4

R52.2

ICD-10 Finland

Other chronic pain

1.8

20.3

293

1623

M48.0

ICD-10 Finland

Spinal stenosis

1.5

20.1

729

5064

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

20.0

4421

39162

R52.9

ICD-10 Finland

Pain, unspecified

1.4

20.0

792

5595

WX142

NOMESCO Finland

Sub-tenon anesthesy

3.8

20.0

158

A02BC01

ATC

omeprazole; systemic

1.3

19.9

2103

17209

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

17.2

19.9

N02BF01

ATC

gabapentin; oral

1.5

19.8

623

4206

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

19.8

174

812

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

+∞

19.8

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.7

19.7

341

1992

CD2S4

NOMESCO Finland

Photography of eye

3.7

19.7

164

N04BD01

ATC

selegiline; oral

2.7

19.6

102

375

R50.9

ICD-10 Finland

Fever, unspecified

1.3

19.6

1275

9780

N04BC04

ATC

ropinirole; oral

2.9

19.5

305

R02

ICPC

Shortness of breath/dyspnoea

1.4

19.5

983

7245

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

19.5

3881

34005

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

19.5

752

5288

UJF32

NOMESCO Finland

Coloscopy

1.3

19.4

1843

14884

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

19.3

361

2155

S01ED01

ATC

timolol; ophthalmic

2.0

19.3

203

1013

N05AA02

ATC

levomepromazine; systemic

1.8

19.2

299

1695

N29

ICPC

Neurological sympt/complt other

2.3

19.1

149

662

H02AB09

ATC

hydrocortisone; systemic

2.0

19.1

219

1128

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

19.0

605

4095

U04

ICPC

Incontinence urine

1.7

18.9

335

1971

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

18.9

811

5812

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

18.9

755

5341

-1, ,

NOMESCO Finland

1.2

18.8

3296

28487

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

18.8

1569

12459

M01AX17

ATC

nimesulide; oral

1.3

18.7

1606

12795

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

18.7

340

RT490, ,

NOMESCO Finland

8.1

18.7

N06BA04

ATC

methylphenidate; oral

1.6

18.6

402

2492

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

18.6

450

2867

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

18.6

750

5315

P99

ICPC

Psychological disorders other

1.8

18.5

280

1574

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

18.5

1504

11895

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

18.5

150

678

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

18.5

502

3285

N03AX18

ATC

lacosamide; systemic

3.0

18.2

263

C07AB07

ATC

bisoprolol; oral

1.2

18.2

3307

28662

A01

ICPC

Pain general/multiple sites

1.4

18.2

702

4934

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.0

18.2

185

913

ZZC00

NOMESCO Finland

Graft of fascia

7.8

18.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

18.0

2697

22915

KMAK, ,

NOMESCO Finland

1.2

18.0

4767

42799

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

18.0

1317

10269

N02BF02

ATC

pregabalin; oral

1.6

18.0

452

2907

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.9

1056

7975

EBA00

NOMESCO Finland

Extraction of tooth

1.2

17.9

3298

28616

Z3226

NOMESCO Finland

Physiotherapist

1.3

17.8

1432

11304

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

17.8

380

2348

P74

ICPC

Anxiety disorder/anxiety state

1.6

17.8

443

2842

D12

ICPC

Constipation

1.8

17.8

250

1376

H40.0

ICD-10 Finland

Glaucoma suspect

1.5

17.7

511

3387

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

17.7

949

7060

G81.1

ICD-10 Finland

Spastic hemiplegia

7.2

17.7

3780X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALIUS]

+∞

17.7

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

66.4

17.7

S29

ICPC

Skin symptom/complaint other

1.3

17.7

1527

12170

A29

ICPC

General symptom/complaint other

1.4

17.6

926

6866

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

17.6

1579

12644

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.7

17.6

306

1792

K02.1

ICD-10 Finland

Caries of dentine

1.2

17.5

5826

53338

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

17.5

137

611

ZXD05

NOMESCO Finland

Urgent procedure

1.2

17.5

2533

21440

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

17.4

1672

13505

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

17.3

687

4856

M25.5

ICD-10 Finland

Pain in joint

1.2

17.2

2767

23660

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

17.1

201

1045

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

17.0

325

1952

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

17.0

526

3539

N06AX12

ATC

bupropion; oral

1.4

17.0

677

4787

L29

ICPC

Musculoskeletal sympt/complt other

1.4

16.9

662

4664

R4110

NOMESCO Finland

Physiotherapy

1.2

16.9

2146

17894

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.4

16.9

113

470

R60.0

ICD-10 Finland

Localized oedema

1.4

16.9

813

5943

P03

ICPC

Feeling depressed

1.3

16.9

1030

7818

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.3

16.9

122

526

WX720

NOMESCO Finland

Own respiration

1.6

16.8

346

2119

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

14.0

16.7

M79.1

ICD-10 Finland

Myalgia

1.3

16.7

1222

9521

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

16.7

250

114

Kela drug reimbursment

Glaucoma

1.5

16.7

453

2964

CEC80

NOMESCO Finland

Partial transposition of extraocular muscle

+∞

16.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

16.6

3683

32457

S01FA01

ATC

atropine; ophthalmic

4.1

16.6

110

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

16.6

211

1126

J01AA02

ATC

doxycycline; systemic

1.2

16.6

6818

63443

R03DC03

ATC

montelukast; oral

1.3

16.5

1430

11390

SPAT1254

SPAT

Administration of medicine

1.3

16.5

1205

9382

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

16.5

333

2031

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

16.4

1557

12546

H54.4

ICD-10 Finland

Blindness, monocular

5.2

16.4

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

16.4

686

4892

R5110, ,

SPAT

1.6

16.4

410

2633

N05AB03

ATC

perphenazine; systemic, rectal

1.8

16.4

265

1521

C03CA01

ATC

furosemide; systemic

1.3

16.4

1664

13520

WX882

NOMESCO Finland

High dependency care

1.8

16.4

240

1338

3768

FHL

Eye examination under general anesthesia

23.0

16.4

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

16.3

976

7385

G40.10

ICD-10 Finland

Simple partial seizures

3.1

16.3

222

34301

ICD-8 Finland

Cerebral spastic infantile paralysis, Diplegia spastica

39.9

16.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

16.3

2754

23649

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

14.2

16.2

N28

ICPC

Limited function/disability (N)

2.3

16.2

118

511

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

16.1

434

2834

Z31.5

ICD-10 Finland

Genetic counselling

1.5

16.1

487

3262

H13

ICPC

Plugged feeling ear

1.3

16.1

1319

10432

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

16.1

5004

45393

NFL22

NOMESCO Finland

Myotomy or tenotomy of hip or thigh

6.7

16.0

H40.11

ICD-10 Finland

Low pressure glaucoma

2.3

15.9

121

533

M03BX02

ATC

tizanidine; oral

1.2

15.9

5561

50927

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

15.9

969

7354

ZY010

NOMESCO Finland

Hospital outpatient

1.5

15.8

497

3356

R06AE07

ATC

cetirizine; oral

1.2

15.7

4096

36566

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.9

15.7

196

1039

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

15.7

6851

63902

R5130, ,

SPAT

5.2

15.7

K59.0

ICD-10 Finland

Constipation

1.6

15.6

400

2585

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.5

827

6147

CGD20

NOMESCO Finland

Laser-assisted in situ keratomileusis

22.0

15.5

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

159.6

15.5

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

5.1

15.4

AAF00

NOMESCO Finland

Ventriculostomy

3.5

15.4

149

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.0

15.4

159

791

G04CA02

ATC

tamsulosin; oral

1.3

15.3

1132

8825

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.0

15.3

157

778

J01CA04

ATC

amoxicillin; systemic

1.2

15.3

8326

79132

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

15.3

1065

8237

N99

ICPC

Neurological disease other

2.5

15.3

371

SPAT1234

SPAT

Support of social functional capacity

1.6

15.3

326

2017

F80.1

ICD-10 Finland

Expressive language disorder

2.4

15.3

407

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.9

15.2

113

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

15.2

790

5845

H44.2

ICD-10 Finland

Degenerative myopia

7.0

15.2

CAC44

NOMESCO Finland

Combined decompression of orbit

28.5

15.1

37404

ICD-8 Finland

Cataract, Secundaria

28.5

15.1

R1260

NOMESCO Finland

Evaluation of communicative skills

2.3

15.1

111

483

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

15.1

2434

20780

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.1

15.1

201

M79.7

ICD-10 Finland

Fibromyalgia

1.7

15.0

291

1756

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.0

15.0

169

866

SFA10

NOMESCO Finland

One-surface restoration

1.2

15.0

5261

48087

J01FF01

ATC

clindamycin; systemic

1.2

15.0

2131

17955

CA1AD

NOMESCO Finland

Orbita CT

5.1

14.9

G04BD08

ATC

solifenacin; oral

1.6

14.9

385

2494

RS142, ,

NOMESCO Finland

4.7

14.8

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

14.8

176

919

R05

ICPC

Cough

1.2

14.8

2071

17419

N05CD08

ATC

midazolam; nasal, systemic

2.0

14.8

161

816

N86

ICPC

Multiple sclerosis

3.1

14.8

188

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

14.7

883

6681

Q66.0

ICD-10 Finland

Talipes equinovarus

5.5

14.7

N05CF02

ATC

zolpidem; oral

1.3

14.6

1348

10813

M02AA10

ATC

ketoprofen; topical

1.3

14.6

1112

8703

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

14.6

266

1580

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.4

14.5

411

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.5

14.5

375

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.9

14.5

167

864

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

14.4

578

4092

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.8

14.3

239

SPAT1053

SPAT

Memory test

1.4

14.3

703

5157

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.6

14.3

307

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

14.2

924

7072

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

14.2

596

4252

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.8

14.2

240

SPAT1139

SPAT

Nutrition survey

1.7

14.2

236

1366

G35

ICD-10 Finland

Multiple sclerosis

2.1

14.1

137

667

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.8

14.1

198

1092

P76

ICPC

Depressive disorder

1.4

14.1

617

4438

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

14.1

200

1107

N03AG04

ATC

vigabatrin; oral

5.6

14.0

N05CD07

ATC

temazepam; oral

1.4

14.0

659

4796

P06

ICPC

Sleep disturbance

1.3

14.0

998

7742

SFA20

NOMESCO Finland

Two-surface restoration

1.2

14.0

5520

50815

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.0

14.0

138

676

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

3.2

13.9

169

R35

ICD-10 Finland

Polyuria

1.5

13.8

408

2720

P29

ICPC

Psychological sympt/compl other

1.4

13.8

694

5108

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

13.8

760

5676

N01

ICPC

Headache

1.3

13.7

1192

9487

R13

ICD-10 Finland

Dysphagia

1.5

13.7

451

3074

G43.3

ICD-10 Finland

Complicated migraine

1.9

13.7

164

859

SPAT1325

SPAT

Vaccination

1.2

13.7

2636

22849

N87

ICPC

Parkinsonism

2.5

13.7

355

A46

ICD-10 Finland

Erysipelas

1.3

13.7

909

6982

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

13.6

1725

14347

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.9

13.6

163

855

-, ,

ICD-10 Finland

2.0

13.5

148

752

3785A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Paralytic strabismus

+∞

13.5

N05AF03

ATC

chlorprothixene; systemic

1.8

13.5

200

1121

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

13.5

150

767

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

13.5

427

2890

G80.3

ICD-10 Finland

Dyskinetic cerebral palsy

33.9

13.5

J01DA01

ATC

[U] cefalexin

1.2

13.4

5445

50156

R15

ICD-10 Finland

Faecal incontinence

1.9

13.4

174

936

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

13.4

399

2665

N06AX03

ATC

mianserin; oral

1.6

13.4

308

1942

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.2

13.4

163

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

13.4

569

4071

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

13.4

732

5461

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

3.6

13.3

115

181

Kela drug reimbursment

Retigabine and vigabatrin

6.0

13.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.3

2463

21265

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.6

13.2

304

1916

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

13.2

559

3999

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

1.9

13.1

159

837

SPAT1262

SPAT

Handing over of treatment supplies

1.3

13.1

1149

9154

SGA01

NOMESCO Finland

Emergency treatment

1.3

13.1

1420

11603

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

13.1

622

4535

H81

ICPC

Excessive ear wax

1.3

13.1

1087

8601

F61.0

ICD-10 Finland

Mixed personality disorders

1.9

13.1

152

789

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

13.1

359

2358

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

13.0

774

5846

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.6

13.0

269

J01EA01

ATC

trimethoprim; systemic

1.2

13.0

2061

17526

N06AB05

ATC

paroxetine; oral

1.5

13.0

454

3132

R4120

NOMESCO Finland

Occupational therapy

1.4

13.0

480

3347

R33

ICD-10 Finland

Retention of urine

1.5

13.0

402

2707

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.3

13.0

388

RT150, ,

NOMESCO Finland

3.3

13.0

146

E66.8

ICD-10 Finland

Other obesity

1.5

13.0

449

3092

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.4

13.0

370

A11

ICPC

Chest pain NOS

1.4

13.0

539

3841

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

12.9

297

1872

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.6

12.9

289

1810

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

12.9

341

2220

WX892

NOMESCO Finland

Monitored bed care

1.4

12.9

502

3535

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

2.9

12.9

209

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.5

12.9

329

R06.5

ICD-10 Finland

Mouth breathing

1.4

12.9

668

4943

3430A

ICD-9 Finland

Infantile cerebral palsy, Diplegic

19.0

12.9

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.6

12.8

277

1720

R03BA05

ATC

fluticasone; inhalant

1.2

12.8

1554

12853

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

12.8

104

472

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.5

12.8

300

H26.2

ICD-10 Finland

Complicated cataract

2.4

12.8

354

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

12.7

165

888

SPAT1307

SPAT

Psychosocial counselling and guidance

1.4

12.7

656

4851

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

12.6

451

3125

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

12.6

1018

8024

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

12.6

359

2376

J01MA02

ATC

ciprofloxacin; systemic

1.2

12.6

2863

25143

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.1

12.6

110

515

R03BA02

ATC

budesonide; inhalant

1.2

12.6

1451

11938

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

12.6

1623

13517

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

12.5

738

5567

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

12.5

1805

15200

F29

ICPC

Eye symptom/complaint other

1.3

12.4

746

5649

193

Kela drug reimbursment

Rasagiline

3.4

12.3

131

Z01.2

ICD-10 Finland

Dental examination

1.2

12.3

4393

39973

S01ED51

ATC

timolol, combinations; ophthalmic

1.5

12.3

399

2714

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.9

12.3

142

736

R01AD09

ATC

mometasone; nasal

1.2

12.3

4144

37546

H17.8

ICD-10 Finland

Other corneal scars and opacities

4.4

12.3

C09CA06

ATC

candesartan; oral

1.2

12.3

1700

14257

D07AC01

ATC

betamethasone; topical

1.2

12.2

2865

25217

RT190, ,

NOMESCO Finland

10.4

12.2

F01

ICPC

Eye pain

1.7

12.2

238

1443

SPAT1097

SPAT

Recording of ECG

1.3

12.1

908

7087

D11

ICPC

Diarrhoea

1.3

12.1

1062

8460

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

12.1

437

3036

Q25.0

ICD-10 Finland

Patent ductus arteriosus

3.6

12.1

104

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

12.1

1112

8911

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

12.1

1605

13402

N06AA10

ATC

nortriptyline; systemic

1.9

12.0

154

826

H02.3

ICD-10 Finland

Blepharochalasis

1.5

12.0

387

2629

R55

ICD-10 Finland

Syncope and collapse

1.3

12.0

708

5342

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

12.0

811

6242

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

18.0

12.0

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.7

12.0

229

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

12.0

718

5431

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

12.0

3272

29149

H02AB07

ATC

prednisone; oral

1.3

12.0

930

7294

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

12.0

1100

8813

R4110, ,

SPAT

1.4

11.9

575

4203

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

11.9

521

3747

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2.8

11.9

208

A02BA02

ATC

ranitidine; systemic

1.3

11.8

1221

9916

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

11.8

911

7137

E23.00

ICD-10 Finland

Panhypopituitarism

3.7

11.8

101

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

11.7

138

720

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

14.6

11.7

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

3.7

11.7

H53.8

ICD-10 Finland

Other visual disturbances

2.2

11.7

458

P01AB01

ATC

metronidazole; oral, rectal

1.2

11.7

3327

29720

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

11.7

217

1298

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.0

11.7

118

584

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.0

11.7

129

659

XX4AW, ,

NOMESCO Finland

3.1

11.7

146

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.7

11.6

227

S01EE01

ATC

latanoprost; ophthalmic

1.5

11.6

316

2072

T82

ICPC

Obesity

1.5

11.6

321

2112

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.9

11.6

146

779

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

2.5

11.6

297

L16

ICPC

Ankle symptom/complaint

1.3

11.6

963

7618

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

11.6

985

7816

37405

ICD-8 Finland

Cataract, Traumatica

12.5

11.6

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

11.5

166

924

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

3.3

11.5

132

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

11.5

3164

28184

SCA02

NOMESCO Finland

Preventive oral health care

1.3

11.5

1084

8712

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.5

11.5

275

104

Kela drug reimbursment

Thyroid insufficiency

1.4

11.5

465

3301

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.7

11.5

215

1290

CEE00

NOMESCO Finland

Posterior fixation suture of extraocular muscle

+∞

11.4

CEC85

NOMESCO Finland

Combined correction of cyclodeviation

+∞

11.4

3506

FHL

Resection of two muscles

+∞

11.4

F71.1

ICD-10 Finland

Moderate mental retardation, significant impairment of behaviour requiring attention or treatment

10.0

11.4

N02AA05

ATC

oxycodone; systemic

1.3

11.4

1007

8025

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

11.4

276

1763

N04BD02

ATC

rasagiline; oral

2.9

11.4

185

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

3.6

11.4

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.4

11.4

306

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

11.4

2112

18201

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

11.3

164

915

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.7

11.3

204

1212

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.8

11.3

178

1019

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.9

11.3

127

654

R4130

NOMESCO Finland

Speech therapy

1.8

11.2

174

991

D01

ICPC

Abdominal pain/cramps general

1.3

11.2

1053

8457

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.5

11.2

255

N88

ICPC

Epilepsy

2.7

11.1

204

H16.0

ICD-10 Finland

Corneal ulcer

1.5

11.1

362

2465

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

11.1

171

971

S80.0

ICD-10 Finland

Contusion of knee

1.4

11.1

605

4510

R03BA01

ATC

beclometasone; inhalant

1.3

11.1

1012

8097

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.2

11.1

135

CAC20

NOMESCO Finland

Lateral decompression of orbit

24.9

11.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

11.1

641

4824

U02

ICPC

Urinary frequency/urgency

1.3

11.1

1061

8542

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

11.0

292

1904

SPAT1365

SPAT

Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools

2.7

11.0

205

N30.0

ICD-10 Finland

Acute cystitis

1.2

11.0

1294

10656

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

11.0

412

2882

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

11.0

354

2405

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

11.0

263

1678

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

11.0

464

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

10.9

714

5468

L01

ICPC

Neck symptom/complaint

1.2

10.9

1267

10421

2AB04, ,

NOMESCO Finland

3.9

10.9

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

10.9

213

1293

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

10.9

810

6318

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

10.9

920

7296

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

10.8

3098

27648

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

10.8

578

4296

S97

ICPC

Chronic ulcer skin

1.5

10.8

328

2203

W19

ICD-10 Finland

Unspecified fall

1.3

10.8

707

5417

M02AA07

ATC

piroxicam; topical

1.2

10.8

2506

21999

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

10.8

396

2762

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.5

10.8

254

D86.3

ICD-10 Finland

Sarcoidosis of skin

4.2

10.7

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.0

10.7

119

610

NXL00

NOMESCO Finland

Biopsy of muscle

3.3

10.7

118

7433A

ICD-9 Finland

Congenital anomalies of eye, Congenital cataract and lens anomalies

27.9

10.7

SFA30

NOMESCO Finland

Three-surface restoration

1.2

10.6

3430

30879

J01FA06

ATC

roxithromycin; oral

1.2

10.6

3116

27854

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

10.6

1005

8077

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

10.6

484

3509

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

10.6

1830

15661

R01AD01

ATC

beclometasone; nasal

1.2

10.6

1145

9347

U07

ICPC

Urine symptom/complaint other

1.4

10.5

480

3479

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.7

10.5

174

1010

D07AA02

ATC

hydrocortisone; topical

1.2

10.5

1228

10107

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.3

10.5

337

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

5.0

10.4

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

10.4

305

2033

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.1

10.4

5086

47112

RL130, ,

NOMESCO Finland

3.2

10.4

125

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

10.4

1167

9560

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

2.4

10.4

282

S06.3

ICD-10 Finland

Focal brain injury

2.3

10.4

350

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

10.4

1987

17149

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.0

10.4

151

3502

FHL

Plication, duplication or fade surgery

+∞

10.4

CED00

NOMESCO Finland

Plication of extraocular muscle

+∞

10.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.6

10.4

265

1715

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

10.4

948

7586

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.0

10.4

101

494

SAA04

NOMESCO Finland

Special examination of mouth

1.4

10.4

460

3318

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

10.4

169

977

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

10.4

1341

11157

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

10.3

242

1536

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.3

1258

10403

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.5

10.3

277

1815

CG2T4

NOMESCO Finland

Topography assessment of cornea

2.5

10.3

248

X78

ICD-10 Finland

Intentional self-harm by sharp object

2.4

10.3

272

H01

ICPC

Ear pain/earache

1.3

10.3

1068

8678

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

10.3

2032

17594

SPAT1211

SPAT

Application of soft bandage

1.3

10.2

661

5056

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

18.7

10.2

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

18.7

10.2

S21

ICPC

Skin texture symptom/complaint

1.3

10.2

1032

8359

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

10.2

473

3439

TKC22

NOMESCO Finland

Catheterisation instruction

1.9

10.2

122

642

SPAT1101

SPAT

Orthostatic test

1.6

10.2

214

1324

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.8

10.2

154

872

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

4.7

10.2

H02AB04

ATC

methylprednisolone; systemic

1.3

10.2

1005

8119

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

2.3

10.1

329

R03AC13

ATC

formoterol; inhalant

1.5

10.1

323

2193

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

10.1

2189

19096

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.7

10.1

198

SPAT1252

SPAT

Overall medication plan or its review

1.4

10.1

384

2697

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

10.0

319

2164

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

10.0

322

2189

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

10.0

805

6340

F79.1

ICD-10 Finland

Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment

8.4

10.0

G04BD07

ATC

tolterodine; oral

1.6

10.0

255

1653

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

9.9

3482

31497

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

9.9

234

1488

L86

ICPC

Back syndrome with radiating pain

1.4

9.9

414

2956

H01AC01

ATC

somatropin; parenteral

2.6

9.9

217

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.2

9.9

345

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

9.9

669

5149

N05AD01

ATC

haloperidol; systemic

1.7

9.9

178

1058

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.1

9.9

443

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

2.7

9.9

189

H29

ICPC

Ear symptom/complaint other

1.3

9.9

801

6318

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

9.8

213

1328

S02

ICPC

Pruritus

1.5

9.8

281

1866

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.5

9.8

312

2117

BAA60

NOMESCO Finland

Total thyroidectomy

1.7

9.8

173

1024

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

9.8

155

890

N03AF03

ATC

rufinamide; oral

19.9

9.8

P20

ICPC

Memory disturbance

1.3

9.7

644

4942

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.7

266

1749

M01AH01

ATC

celecoxib; oral

1.2

9.7

1178

9729

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

9.7

1016

8257

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

9.7

603

4586

N05BE01

ATC

buspirone; oral

1.6

9.7

203

1255

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

9.7

370

2601

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

9.7

574

4338

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

9.6

566

4270

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.5

9.6

238

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.6

9.6

241

1555

A98

ICPC

Health maint/preventive medicine

1.4

9.6

10187

99854

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

9.6

192

1175

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.1

9.6

409

XQ800

NOMESCO Finland

Prick test

1.3

9.6

643

4947

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.8

9.5

146

830

XCH00

NOMESCO Finland

Eye pressure measurement

1.5

9.5

266

1758

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.3

9.5

102

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.4

9.5

264

XCW12

NOMESCO Finland

Assessment of colour vision

10.0

9.5

N05AN01

ATC

lithium; oral

1.7

9.5

181

1094

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

9.4

267

1769

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

9.4

842

6721

P52.2

ICD-10 Finland

Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn

99.8

9.4

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

9.4

728

5709

74439

ICD-8 Finland

Congenital anomalies of eye, Cataracta NUD

17.5

9.4

H49.4

ICD-10 Finland

Progressive external ophthalmoplegia

+∞

9.4

RT274, ,

NOMESCO Finland

4.1

9.4

C10AA03

ATC

pravastatin; oral

1.4

9.3

359

2528

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

12.3

9.3

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

8.0

9.3

L05

ICPC

Flank/axilla symptom/complaint

1.4

9.3

411

2966

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.4

9.3

391

2799

Z50.5

ICD-10 Finland

Speech therapy

1.8

9.3

121

656

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.6

9.2

223

1427

H26.01

ICD-10 Finland

Infantile, juvenile and presenile cataract

4.9

9.2

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.0

9.2

102

523

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.3

9.2

292

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

9.2

302

2062

G91.8

ICD-10 Finland

Other hydrocephalus

9.5

9.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

9.2

435

3174

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.9

9.2

118

636

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

9.2

1412

11940

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.6

9.2

216

1374

L13

ICPC

Hip symptom/complaint

1.2

9.2

1177

9779

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.8

9.2

130

723

S01FA04

ATC

cyclopentolate; ophthalmic

2.2

9.2

312

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.5

9.2

220

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

7.2

9.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

9.1

220

1407

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

9.1

5011

46613

J01MA12

ATC

levofloxacin; systemic

1.2

9.1

1173

9746

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.3

9.1

275

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

9.1

260

1727

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

9.1

3512

31935

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

9.1

256

1696

S15

ICPC

Foreign body in skin

1.4

9.1

420

3054

V200A

ICD-9 Finland

Health supervision of infant or child, Foundling

3.7

9.1

R09

ICPC

Sinus symptom/complaint

1.3

9.1

692

5415

G03DC03

ATC

lynestrenol; oral

1.7

9.0

175

1062

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.0

2720

24307

SPAT1377

SPAT

Polysomnography

1.6

9.0

219

1404

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2.4

9.0

258

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

9.0

2225

19591

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1.9

9.0

112

598

G72.9

ICD-10 Finland

Myopathy, unspecified

2.4

9.0

234

P07.2

ICD-10 Finland

Extreme immaturity

9.0

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.7

9.0

146

846

N89

ICPC

Migraine

1.4

9.0

346

2439

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

1.8

8.9

118

642

R06AX27

ATC

desloratadine; oral

1.2

8.9

2679

23932

R05

ICD-10 Finland

Cough

1.2

8.9

1671

14384

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

8.9

516

3890

R04

ICPC

Breathing problem other

1.5

8.8

256

1707

J01FA10

ATC

azithromycin; systemic

1.1

8.8

5567

52197

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

8.8

2122

18646

K03.66

ICD-10 Finland

Tooth plaque

1.3

8.8

598

4609

R51

ICD-10 Finland

Headache

1.4

8.8

463

3438

IEV99

NOMESCO Finland

Other psychiatric network intervention

2.2

8.8

337

J01DA09

ATC

[U] cefadroxil

1.2

8.8

2116

18591

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

8.8

599

4619

KH1AD

NOMESCO Finland

CT of urinary organs

1.6

8.8

216

1390

P80

ICPC

Personality disorder

2.6

8.8

178

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

8.8

300

2068

H35.1

ICD-10 Finland

Retinopathy of prematurity

8.6

8.7

G40

ICD-10 Finland

Epilepsy

2.2

8.7

312

K07.60

ICD-10 Finland

Snapping jaw

1.4

8.7

426

3125

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.7

8.7

141

815

L04AX01

ATC

azathioprine; systemic

1.4

8.7

313

2177

G40.89

ICD-10 Finland

Other epilepsy

2.8

8.7

145

SDA03

NOMESCO Finland

Periodontal treatment

1.1

8.7

3495

31841

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.6

8.7

194

1220

S01BC05

ATC

ketorolac; ophthalmic

1.6

8.7

187

1166

-50

ICPC

Medication/prescr/renewal

1.5

8.7

255

1705

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

3.2

8.7

103

3795A

ICD-9 Finland

Other disorders of eye, Nystagmus and other irregular eye movements

49.8

8.7

R01AD12

ATC

fluticasone furoate; nasal

1.1

8.7

2876

25867

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.8

8.6

129

729

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

8.6

327

2297

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

6.5

8.6

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

2.4

8.6

227

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

1.7

8.6

151

894

WX290

NOMESCO Finland

Other blockage of nerve

1.1

8.6

4518

41864

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

8.6

529

4024

F80.8

ICD-10 Finland

Other developmental disorders of speech and language

3.2

8.5

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

2.4

8.5

234

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

1.8

8.5

127

719

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.9

8.5

108

582

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.4

8.5

344

2448

P01

ICPC

Feeling anxious/nervous/tense

1.2

8.5

1269

10704

78112

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Nystagmus

27.4

8.5

R96

ICPC

Asthma

1.3

8.4

683

5388

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.3

8.4

548

4201

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

4.1

8.4

T90

ICPC

Diabetes non-insulin dependent

1.2

8.4

1393

11861

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

8.4

326

2302

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

1.7

8.4

136

788

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.8

8.4

113

620

Z2221

NOMESCO Finland

Medical doctor

1.2

8.4

2180

19261

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

8.4

224

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

8.4

1649

14252

J46

ICD-10 Finland

Status asthmaticus

1.6

8.3

191

1209

FM2CE, ,

NOMESCO Finland

2.0

8.3

411

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.0

8.3

445

H15.0

ICD-10 Finland

Scleritis

3.0

8.3

116

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

4.3

8.3

M70.6

ICD-10 Finland

Trochanteric bursitis

1.2

8.3

845

6846

H60.8

ICD-10 Finland

Other otitis externa

1.5

8.3

217

1415

3672A

ICD-9 Finland

Disorders of refraction and accommodation, Astigmatism

+∞

8.3

CEA00

NOMESCO Finland

Biopsy of extraocular muscle

+∞

8.3

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

8.3

1357

11536

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

8.3

806

6497

RD210, ,

NOMESCO Finland

1.7

8.3

160

971

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

8.3

664

5230

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

8.3

121

680

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

2.1

8.3

326

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.2

8.3

866

7041

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.4

8.3

397

2907

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

2.8

8.2

144

L12

ICPC

Hand/finger symptom/complaint

1.2

8.2

1325

11249

SPAT1243

SPAT

Psychiatric/psychological examination

1.5

8.2

254

1717

K30

ICD-10 Finland

Functional dyspepsia

1.3

8.2

817

6604

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

8.2

154

928

R52.1

ICD-10 Finland

Chronic intractable pain

2.1

8.2

327

R06AX22

ATC

ebastine; oral

1.2

8.2

1346

11446

J05AB01

ATC

aciclovir; systemic

1.2

8.2

1653

14310

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

4.1

8.2

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.8

8.2

115

639

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

8.2

615

4806

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

8.2

256

1736

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

8.1

181

1138

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

2.9

8.1

123

H92.0

ICD-10 Finland

Otalgia

1.3

8.1

506

3853

RT160, ,

NOMESCO Finland

3.3

8.1

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

2.5

8.1

203

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

8.1

298

2083

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.5

8.1

238

1592

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

2.0

8.1

402

EJC20

NOMESCO Finland

Operation on frenulum of tongue

2.7

8.1

151

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.8

8.1

109

598

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.4

8.1

343

2460

M01AE02

ATC

naproxen; oral, rectal

1.1

8.1

5207

48768

OAB50, ,

SPAT

1.4

8.1

336

2402

Z00.0

ICD-10 Finland

General medical examination

1.2

8.1

1503

12925

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.6

8.1

180

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

4.5

8.1

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

33.2

8.1

37898

ICD-8 Finland

Other diseases of eye, Disease of eyeball, ocular muscle and orbit NEC

4.7

8.1

N03AX22

ATC

perampanel; oral

3.6

8.1

L18

ICPC

Muscle pain

1.4

8.0

300

2103

L03AX13

ATC

glatiramer acetate; parenteral

2.6

8.0

163

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

8.0

1526

13146

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.1

8.0

2544

22788

N05AE04

ATC

ziprasidone; systemic

2.3

8.0

266

B01AC04

ATC

clopidogrel; oral

1.3

8.0

789

6372

Z00.8

ICD-10 Finland

Other general examinations

1.3

8.0

585

4555

Z63.8

ICD-10 Finland

Other specified problems related to primary support group

2.9

8.0

119

3242

FHL

Levator resection

21.9

8.0

E000001, ,

ATC

1.2

8.0

1637

14189

F40.2

ICD-10 Finland

Specific (isolated) phobias

2.1

8.0

344

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.0

8.0

425

A03

ICPC

Fever

1.2

8.0

1618

14014

N03AB02

ATC

phenytoin; systemic

2.2

8.0

273

R5599

NOMESCO Finland

Other rehabilitation service

1.6

8.0

187

1192

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

7.9

904

7417

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

2.2

7.9

267

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

7.9

1973

17363

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

7.9

414

3072

J02AC01

ATC

fluconazole; systemic

1.1

7.9

3393

30993

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

7.9

607

4755

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.8

7.9

115

646

Q21.10

ICD-10 Finland

Persistent ostium secundum

2.3

7.9

255

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

3.1

7.9

104

CKC12

NOMESCO Finland

Photocoagulation of retina

1.5

7.9

240

1618

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

7.9

428

3195

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

7.9

345

2488

A10BJ05

ATC

dulaglutide; parenteral

1.8

7.9

116

654

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

7.9

962

7951

R51.81

ICD-10 Finland

Facial pain NOS

1.6

7.9

168

1047

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

7.9

1656

14386

S01

ICPC

Pain/tenderness of skin

1.4

7.8

309

2188

R03AC03

ATC

terbutaline; inhalant

1.2

7.8

1041

8679

U05

ICPC

Urination problems other

1.4

7.8

280

1949

M01AH05

ATC

etoricoxib; oral

1.1

7.8

5258

49329

R49.08

ICD-10 Finland

Other specified dysphonia

1.7

7.8

143

857

WF099

NOMESCO Finland

Other radiotherapy

2.7

7.8

154

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

1.9

7.8

505

L15

ICPC

Knee symptom/complaint

1.2

7.8

1803

15776

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.1

7.8

334

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

7.8

627

4942

G04BD09

ATC

trospium; oral

1.7

7.8

126

730

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

7.8

2278

20283

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.0

7.8

381

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

2.2

7.8

263

A01AB09

ATC

miconazole; local oral

1.3

7.8

567

4413

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

3.6

7.8

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

3.6

7.8

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

2.6

7.8

160

L04

ICPC

Chest symptom/complaint

1.3

7.8

434

3255

F79

ICD-10 Finland

Unspecified mental retardation

9.4

7.7

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

7.7

1329

11347

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

2.9

7.7

116

C09CA01

ATC

losartan; oral

1.2

7.7

1559

13496

M54.2

ICD-10 Finland

Cervicalgia

1.3

7.7

567

4419

L84

ICPC

Back syndrome without radiat pain

1.4

7.7

329

2364

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

2.0

7.7

376

H15.1

ICD-10 Finland

Episcleritis

1.8

7.7

108

601

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

7.7

1601

13894

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

4.2

7.7

M54.3

ICD-10 Finland

Sciatica

1.4

7.7

387

2858

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

2.7

7.6

150

F17

ICPC

Glasses symptom/complaint

2.4

7.6

203

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

5.9

7.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

7.6

1718

15001

109

Kela drug reimbursment

Multiple sclerosis

1.9

7.6

481

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

7.6

900

7414

A10BJ06

ATC

semaglutide; parenteral

1.4

7.6

295

2084

N04BC09

ATC

rotigotine; transdermal

2.8

7.6

128

Z61.8

ICD-10 Finland

Other negative life events in childhood

3.1

7.6

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

7.6

396

2939

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.2

7.6

266

R00.2

ICD-10 Finland

Palpitations

1.3

7.6

581

4553

F34.1

ICD-10 Finland

Dysthymia

1.4

7.6

276

1928

N06AX05

ATC

trazodone; oral

1.6

7.6

177

1128

H57.0

ICD-10 Finland

Anomalies of pupillary function

2.3

7.5

223

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.4

7.5

320

2299

37520

ICD-8 Finland

Glaucoma, Secondary

10.0

7.5

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.4

7.5

317

2274

R03BA08

ATC

ciclesonide; inhalant

1.3

7.5

610

4816

IGV01

NOMESCO Finland

Psychiatric network contact

1.8

7.5

105

584

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.6

7.5

149

913

RF120, ,

NOMESCO Finland

1.9

7.5

428

N02CD01

ATC

erenumab; parenteral

2.0

7.5

380

P72

ICPC

Schizophrenia

1.7

7.5

132

784

L19

ICPC

Muscle symptom/complaint NOS

1.5

7.5

188

1218

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

7.5

351

2563

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2.6

7.5

152

SPAT1104

SPAT

Monitoring of emergency patient

1.3

7.5

413

3094

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

7.4

311

2227

G04BD11

ATC

fesoterodine; oral

1.6

7.4

151

931

7436B

ICD-9 Finland

Congenital anomalies of eyelids, lachrymal system and orbit[PTOSIS CONGENITA]

79.9

7.4

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

7.4

434

3279

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

7.4

768

6239

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.3

7.4

577

4532

N18

ICPC

Paralysis/weakness

1.8

7.4

103

572

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

7.4

424

3194

S22

ICPC

Nail symptom/complaint

1.3

7.4

423

3186

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.5

7.4

192

1254

R01AD58

ATC

fluticasone, combinations; nasal

1.1

7.4

2179

19409

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

3.5

7.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.2

7.4

728

5883

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.7

7.3

134

803

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

7.6

7.3

R29

ICPC

Respiratory symptom/complaint other

1.3

7.3

485

3728

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

7.3

417

3139

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

3.7

7.3

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.6

7.3

177

1138

RK110, ,

NOMESCO Finland

2.3

7.3

220

3788X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other disorders of binocular eye movements

+∞

7.3

Z08

ICPC

Social welfare problem

1.9

7.3

489

E000006, ,

ATC

1.3

7.3

463

3541

M54.1

ICD-10 Finland

Radiculopathy

1.4

7.3

254

1762

S01EA03

ATC

apraclonidine; ophthalmic

2.3

7.3

233

K08.80

ICD-10 Finland

Toothache NOS

1.3

7.2

685

5508

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.5

7.2

180

1164

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.7

7.2

112

642

N06AA06

ATC

trimipramine; systemic

1.6

7.2

148

914

K04.0

ICD-10 Finland

Pulpitis

1.2

7.2

774

6310

-31

ICPC

Medical examin/health eval partial

1.3

7.2

472

3622

C07AB02

ATC

metoprolol; systemic

1.2

7.2

1106

9345

N03AX23

ATC

brivaracetam; systemic

3.1

7.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

7.2

560

4398

G82.2

ICD-10 Finland

Paraplegia, unspecified

2.8

7.2

121

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

2.4

7.2

203

J01CA08

ATC

pivmecillinam; oral

1.1

7.2

3483

32014

G50.1

ICD-10 Finland

Atypical facial pain

1.7

7.2

115

666

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.4

7.2

185

C10AC01

ATC

colestyramine; oral

1.6

7.1

171

1096

78110

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Diplopia

29.9

7.1

7423A

ICD-9 Finland

Other congenital anomalies of nervous system, Congenital hydrocephalus

29.9

7.1

3046, ,

Kela drug reimbursment

29.9

7.1

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.1

7.1

306

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.5

7.1

206

1376

AA3AD

NOMESCO Finland

CT of face

2.3

7.1

235

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.3

7.1

210

G03DB01

ATC

dydrogesterone; oral

1.2

7.1

967

8079

D21

ICPC

Swallowing problem

1.9

7.1

422

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

2.4

7.1

204

L14

ICPC

Leg/thigh symptom/complaint

1.3

7.1

526

4105

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.5

7.1

184

1201

R03DA04

ATC

theophylline; systemic, rectal

1.4

7.1

261

1828

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

266

418

6.48

160.44

1.1

1.84

10.49

nmol/l

1.26

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3043

22285

1.50

72.08

2.3

2.1

185.04

205.72

u/l

0.65

2854

21011

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4796

38492

1.44

70.18

7.8

6.6

1.21

1.22

mmol/l

0.72

4092

32906

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4382

34869

1.43

65.74

7.5

6.1

1.21

mmol/l

1.64

4069

32037

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7746

68733

1.45

59.70

4.8

4.0

14.73

14.57

pmol/l

7.30

7163

63277

(3013826) Glucose [Moles/volume] in Serum or Plasma

5610

47406

1.38

55.29

5.7

4.6

6.51

6.53

mmol/l

0.26

5273

43748

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7087

62683

1.38

49.70

7.6

7.1

78.94

77.90

u/l

0.91

6704

59198

(3019550) Sodium [Moles/volume] in Serum or Plasma

9324

86746

1.56

48.84

16.6

13.3

139.68

139.62

mmol/l

1.81

9111

84492

(3024561) Albumin [Mass/volume] in Serum or Plasma

4087

33310

1.36

48.17

5.1

4.9

36.19

g/l

0.00

3800

31101

(3023103) Potassium [Moles/volume] in Serum or Plasma

9339

87000

1.55

47.70

16.7

13.4

3.94

mmol/l

0.31

9104

84529

(3035350) Ketones [Presence] in Urine by Test strip

4992

42157

1.34

45.60

4.0

3.4

0.00

estimate

2.80

1057

8475

(3009261) Glucose [Presence] in Urine by Test strip

5019

42543

1.33

44.12

4.1

3.4

0.00

estimate

0.17

1017

7952

(3021601) Nitrite [Presence] in Urine by Test strip

4977

42194

1.33

43.43

5.2

4.6

0.00

estimate

2.09

1037

8164

(3018418) pH of Serum or Plasma

2869

22400

1.38

43.21

4.2

3.9

7.40

0.05

560

4342

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

452

2254

2.04

42.75

2.7

1.9

4.94

4.13

iu/l

0.90

210

885

(3022217) INR in Platelet poor plasma by Coagulation assay

4043

33345

1.33

42.34

12.3

12.0

1.17

1.19

inr

0.86

1262

10180

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8719

80537

1.43

42.25

5.6

4.6

2.41

2.01

mu/l

0.58

8184

75091

(40760892) CBC W Ordered Manual Differential panel - Blood

4832

40941

1.32

41.67

7.7

6.6

—

(3026008) Bacteria identified in Urine by Culture

3055

24212

1.36

41.52

3.3

2.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7027

62785

1.34

41.49

4.4

3.9

10.60

10.67

mm/h

0.17

6568

58569

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3390

27343

1.34

40.92

3.6

3.2

29.33

71.14

ng/l

1.32

2033

16167

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

444

2237

2.02

40.81

1.4

1.6

436.39

497.50

mg/l

2.65

421

2130

(3001604) Monocytes [#/volume] in Blood

5081

43499

1.31

40.04

7.2

6.1

0.56

0.57

e9/l

0.05

4481

37880

(3006315) Basophils [#/volume] in Blood

5087

43595

1.31

39.62

7.2

6.1

0.04

e9/l

0.74

4480

37912

(3044889) 12 lead EKG panel

6275

55363

1.31

39.35

3.7

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2825

22268

1.36

39.32

4.6

3.7

0.00

estimate

3.67

1006

7913

(3019198) Lymphocytes [#/volume] in Blood

5231

45082

1.31

38.72

7.1

6.1

1.98

e9/l

0.01

4706

40210

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1210

8222

1.53

38.03

2.4

2.2

359.42

373.14

nmol/l

1.67

1128

7581

(3013115) Eosinophils [#/volume] in Blood

5224

45130

1.30

37.46

7.7

6.4

0.19

e9/l

0.16

4678

39893

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

141

5.19

35.62

1.1

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6307

56064

1.29

35.40

5.1

4.1

1000.13

1526.50

e6/l

0.57

117

672

(3037467) Urinalysis macro (dipstick) panel - Urine

6593

58958

1.30

35.30

4.8

4.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3664

30362

1.31

35.18

1.9

97.35

97.14

pmol/l

0.10

1938

16054

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3109

25205

1.32

34.92

2.8

2.5

54.12

61.45

u/l

1.60

2854

23355

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4780

41064

1.29

34.73

6.0

11.17

11.27

umol/l

0.17

4514

38777

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9363

88277

1.46

34.70

15.0

12.2

21.15

21.85

mg/l

1.25

7470

68249

(3019309) Folate [Moles/volume] in Red Blood Cells

1716

12684

1.41

34.70

1.7

1235.89

1164.02

nmol/l

2.43

1328

9754

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4147

34985

1.30

34.65

2.6

2.3

75.08

74.97

nmol/l

0.10

3805

32130

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

389

1986

1.99

34.44

1.4

1.5

3.67

3.66

mmol/l

0.08

359

1872

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

389

2000

1.97

33.76

1.6

1.7

16.62

23.30

e6/l

0.61

313

1522

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

389

2002

1.97

33.66

1.7

1199.98

1191.77

e6/l

0.00

325

1606

(3015736) pH of Urine

4054

34313

1.29

32.31

3.7

3.1

5.88

5.92

0.36

308

3239

(3013650) Neutrophils [#/volume] in Blood by Automated count

5662

49954

1.27

32.21

10.5

9.0

4.05

4.00

e9/l

0.83

5008

43693

(3023368) Bacteria identified in Blood by Culture

2461

19507

1.33

31.77

4.5

4.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

268

1229

2.20

31.57

5.1

399.94

369.12

umol/l

2.08

241

1076

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3872

32661

1.28

31.44

4.2

3.5

—

(3016502) Oxygen saturation in Arterial blood

1017

6923

1.51

31.39

9.7

7.9

95.88

95.91

0.05

983

6643

(3019150) Specific gravity of Urine by Refractometry

2332

18412

1.33

30.77

4.4

3.7

1.02

kg/l

0.14

323

2782

(3015377) Calcium [Moles/volume] in Serum or Plasma

3165

26073

1.30

30.71

3.0

3.2

2.35

2.36

mmol/l

1.95

2815

23223

(3044290) Cell count panel - Cerebral spinal fluid

362

1878

1.95

30.62

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

1117

7796

1.48

30.46

9.4

7.5

1.20

0.96

mmol/l

1.41

881

6111

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1117

7800

1.48

30.38

9.3

7.4

5.14

5.08

kpa

1.31

1064

7440

(3022096) Basophils/100 leukocytes in Blood

4584

39595

1.27

30.33

7.3

6.3

0.67

0.28

4321

37083

(3027801) Oxygen [Partial pressure] in Arterial blood

1116

7798

1.48

30.24

9.3

7.4

12.79

12.87

kpa

0.18

1068

7436

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1396

10177

1.42

30.17

6.9

6.4

1.08

1.07

mmol/l

0.58

1310

9543

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9657

92026

1.47

29.53

16.2

13.5

72.73

72.86

umol/l

0.16

9652

91997

(3006504) Eosinophils/100 leukocytes in Blood

4715

40966

1.26

29.34

7.3

6.3

2.81

2.86

0.78

4460

38503

(3019069) Monocytes/100 leukocytes in Blood

4732

41218

1.26

28.50

7.7

6.5

8.37

8.35

0.25

4480

38804

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3387

28366

1.28

28.32

3.5

3.3

30.66

33.26

u/l

1.65

3209

26994

(3007853) Bacteria identified in Skin by Aerobe culture

1350

9888

1.41

28.28

2.0

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

940

6432

1.50

28.19

10.1

8.1

123.49

122.17

g/l

1.13

915

6243

(3002030) Lymphocytes/100 leukocytes in Blood

4882

42765

1.25

27.69

7.3

6.3

29.17

29.31

0.43

4631

40388

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1618

12274

1.37

27.39

4.4

3.9

0.82

mmol/l

0.02

1525

11571

(3018010) Neutrophils/100 leukocytes in Blood

4815

42145

1.25

27.38

7.1

6.1

56.28

56.14

0.35

4555

39786

(3021960) Folate [Moles/volume] in Serum or Plasma

2119

16750

1.32

27.26

1.5

20.52

20.45

nmol/l

0.07

1863

14543

(3000850) Epithelial cells [#/volume] in Urine

2110

16702

1.32

26.82

2.9

2.5

6.21

6.46

e6/l

0.31

1905

14918

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2012

15870

1.32

26.14

1.7

1.6

44269456.44

31533700.77

pmol/l

0.37

1710

13481

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

858

5858

1.50

25.94

4.0

3.3

4.54

4.56

pmol/l

0.24

782

5245

(40761511) CBC panel - Blood by Automated count

9663

92433

1.43

25.53

14.1

11.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

184

790

2.34

25.42

1.2

1.1

35.84

39.02

mg/l

0.55

149

664

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

180

766

2.36

25.38

1.1

224.74

243.99

mg/l

0.74

155

680

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

186

806

2.32

25.16

1.8

1.5

—

(3026782) Osmolality of Urine

1981

15775

1.31

23.75

3.2

2.8

541.34

545.10

mosm/kgh2o

0.30

1703

13538

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2230

18041

1.29

23.72

3.1

3.0

1058.85

1206.23

ng/l

0.81

1854

15190

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7976

74444

1.27

23.53

5.4

4.9

38.82

38.70

mmol/mol

0.53

7462

69766

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8545

80455

1.29

23.35

4.4

3.9

5.80

5.78

mmol/l

0.72

7888

74499

(3021589) Normoblasts [#/volume] in Blood

4426

38841

1.23

23.11

10.6

9.0

0.00

e9/l

0.42

3663

31688

(3008152) Bicarbonate [Moles/volume] in Arterial blood

639

4209

1.55

22.81

8.6

6.6

24.59

24.46

mmol/l

0.40

611

3987

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

740

2.31

22.80

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1504

11585

1.34

22.69

2.6

2.4

29.75

29.76

0.02

1455

11249

(3002385) Erythrocyte distribution width [Ratio]

8299

77940

1.27

22.58

18.2

14.6

15.01

14.78

0.18

8161

76578

(3019060) Gas panel - Arterial blood

653

4353

1.53

22.06

6.3

4.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

511

2.55

21.82

1.1

1.05

1.06

u/l

0.12

235

(3011397) Hemoglobin [Presence] in Urine by Test strip

2387

19659

1.27

21.73

3.9

3.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4643

41114

1.22

21.72

3.2

2.9

95.68

100.35

ug/l

0.92

4329

38632

(36304419) Bacteria [Presence] in Urine

2634

21973

1.26

21.47

3.4

3.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

938

6759

1.42

21.27

2.9

2.7

10.39

10.38

g/l

0.03

855

6225

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2452

20313

1.26

21.16

2.4

2.3

2.82

mg/l

0.00

2121

17522

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1531

11937

1.32

21.12

1.9

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

2869

24215

1.25

21.00

3.7

3.1

63.50

78.73

e6/l

0.31

2250

18310

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1094

8126

1.38

20.74

1.9

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9641

92643

1.38

20.53

10.9

9.4

26.40

26.38

u/l

0.03

9357

89753

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

148

637

2.33

20.43

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

2645

22191

1.25

20.30

3.5

3.0

0.39

0.37

e6/l

0.18

2051

16610

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2272

18735

1.26

20.25

2.0

1.9

1.06

1.11

mg/l

0.30

1697

13946

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2666

22392

1.25

20.25

1.4

1.3

1.11

1.79

u/ml

5.37

773

6045

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1081

8062

1.37

19.95

1.8

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

153

675

2.28

19.95

1.3

1.2

1.87

1.92

mmol/l

0.32

138

635

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1882

15204

1.28

19.79

1.3

24.40

30.02

iu/ml

1.12

587

4758

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1186

9019

1.35

19.29

7.1

6.0

—

(3018095) Leukocytes [#/volume] in Urine

3368

29129

1.22

19.19

4.2

3.6

68.87

85.85

e6/l

0.79

2422

19872

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

200

1009

1.99

18.48

3.1

2.8

21.15

21.36

nmol/l

0.08

192

967

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

148

669

2.22

18.25

19.0

1531.92

2824.14

nmol/l

0.44

141

650

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

183

908

2.03

17.73

1.1

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1155

8854

1.34

17.73

8.7

7.3

104.64

104.54

mmol/l

0.28

1155

8847

(3037522) Nuclear Ab [Titer] in Serum

1545

12335

1.29

17.64

1.4

471.29

558.60

titre

1.20

317

2458

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

779

5622

1.41

17.44

4.2

4.0

80.85

83.28

ng/l

0.26

679

4961

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

768

5531

1.41

17.40

11.7

8.5

24.95

24.70

mmol/l

1.23

762

5504

(3041096) Erythrocytes [Presence] in Urine by Automated

2771

23683

1.22

17.38

3.6

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

2780

23779

1.22

17.28

3.4

3.3

7.72

7.85

mmol/l

0.70

2401

20589

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

192

989

1.95

16.76

1.1

—

4.03

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2447

20786

1.22

16.08

1.7

1.6

1.37

1.38

mmol/l

0.13

2113

17841

(3022948) Iron [Moles/volume] in Serum or Plasma

1517

12224

1.28

15.97

2.6

2.4

13.30

13.67

umol/l

1.27

1415

11480

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

235

2.94

15.37

2.6

2.2

18.80

15.84

umol/l

1.07

235

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

138

652

2.12

15.31

14.4

13.0

881.31

821.59

nmol/l

0.75

133

631

(3042936) Bacteria identified in Isolate by Culture

1370

10959

1.28

15.25

2.2

2.0

—

(3000991) Gas panel - Venous blood

893

6738

1.35

15.18

11.1

8.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

983

7534

1.33

15.03

3.7

3.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

734

5379

1.39

14.99

6.1

4.7

5.16

5.10

kpa

1.09

708

5133

(3014111) Lactate [Moles/volume] in Serum or Plasma

861

6482

1.35

14.84

9.6

7.7

1.32

1.34

mmol/l

0.32

836

6329

(3007461) Platelets [#/volume] in Blood

10200

99526

1.46

14.70

22.4

17.9

257.71

258.10

e9/l

0.24

10005

97098

(3009343) pH of Capillary blood

725

5323

1.38

14.64

6.2

4.7

7.42

7.41

0.22

586

(3012544) pH of Venous blood

977

7521

1.32

14.47

5.7

4.8

7.36

7.37

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

543

3799

1.45

14.43

12.2

10.1

—

(3024731) MCV [Entitic volume]

10205

99611

1.46

14.39

22.3

17.8

90.17

90.20

0.24

10095

98403

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1733

14346

1.24

14.34

1.3

8.85

11.08

u/ml

0.70

688

5805

(3010813) Leukocytes [#/volume] in Blood

10207

99639

1.46

14.33

22.4

17.8

6.76

6.71

e9/l

1.06

9988

96943

(3035941) MCH [Entitic mass]

10204

99606

1.46

14.31

22.3

17.7

30.08

30.10

0.36

10093

98400

(3007164) IgA [Mass/volume] in Serum or Plasma

2291

19527

1.21

14.30

1.5

2.19

2.23

g/l

0.61

1432

12051

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

704

5165

1.38

14.28

6.2

4.7

1.43

1.44

mmol/l

0.04

523

3763

(3000963) Hemoglobin [Mass/volume] in Blood

10208

99661

1.46

14.21

22.6

17.9

135.58

135.65

g/l

0.20

10097

98454

(3026361) Erythrocytes [#/volume] in Blood

10205

99627

1.46

14.20

22.4

17.8

4.54

4.53

e12/l

0.58

9982

96976

(40768797) Stomach Pathology biopsy report

1341

10791

1.27

14.17

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

2.65

14.16

1.3

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

10187

99431

1.44

14.06

22.7

17.9

40.39

40.52

0.51

9567

94182

(3018405) Lactate [Moles/volume] in Arterial blood

365

2367

1.56

14.04

4.9

3.8

1.31

1.39

mmol/l

0.96

359

2323

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1383

11188

1.27

13.97

2.6

2.4

2.44

2.40

g/l

1.64

1272

10405

(3021447) Carbon dioxide [Partial pressure] in Venous blood

949

7318

1.32

13.87

5.8

4.8

5.87

5.84

kpa

0.51

929

7100

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

411

2744

1.51

13.84

6.4

4.8

1.74

1.69

0.37

388

2547

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

368

2401

1.55

13.78

2.5

2.4

881.69

476.28

ug/l

0.32

330

2235

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

493

3421

1.46

13.69

2.0

39.17

39.65

u/l

0.21

450

3097

(3025159) Blasts/100 leukocytes in Blood

822

6223

1.34

13.64

4.6

4.3

0.44

0.28

0.17

197

1593

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1700

14132

1.24

13.46

3.8

3.4

307.19

491.78

ng/l

1.07

1190

9768

(3017181) Myelocytes/100 leukocytes in Blood

888

6813

1.33

13.45

4.5

4.2

0.92

0.89

0.09

260

2176

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8317

79354

1.20

13.08

12.8

11.0

88.07

87.57

ml/min/173m2

1.17

6769

64711

(3002032) Base excess in Venous blood by calculation

939

7291

1.31

13.05

5.8

4.8

1.72

1.78

mmol/l

0.20

800

6108

(40761535) Cells panel - Urine sediment

802

6091

1.34

13.02

4.1

3.4

—

(4200892) Spirometry reversibility

746

5612

1.35

12.91

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

266

1635

1.64

12.85

2.7

2.9

33.65

34.34

umol/l

0.16

248

1499

(3005322) IgE [Units/volume] in Serum or Plasma

832

6366

1.33

12.84

1.4

1.3

237.24

224.10

u/ml

0.14

771

5903

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

518

3675

1.42

12.78

6.8

5.1

24.57

24.51

mmol/l

0.21

486

3480

(3047181) Lactate [Moles/volume] in Blood

350

2303

1.53

12.64

7.1

5.4

1.29

1.28

mmol/l

0.08

311

2021

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1617

13453

1.23

12.64

3.0

2.6

0.99

1.12

e6/l

0.79

949

7450

(3024354) Oxygen [Partial pressure] in Venous blood

807

6164

1.33

12.60

5.5

4.4

4.89

4.76

kpa

1.05

787

5973

(3020891) Body temperature

405

2750

1.49

12.59

5.9

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6431

60155

1.16

12.56

3.5

3.0

44.73

42.08

u/l

1.07

6077

56869

(3016018) Differential panel - Cerebral spinal fluid

183

1025

1.79

12.42

1.9

1.7

—

(40761536) Microorganisms panel - Urine sediment

949

7432

1.30

12.36

4.7

3.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

816

6260

1.32

12.36

4.2

4.0

0.66

0.65

0.08

221

1908

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

737

5584

1.34

12.16

2.3

6.89

7.38

ug/l

0.21

620

4877

(3022313) Gas panel - Capillary blood

552

4001

1.39

12.06

6.7

5.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4406

40152

1.16

11.99

2.7

2.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

397

2715

1.47

11.93

6.6

4.9

0.91

0.05

375

2523

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1269

10352

1.25

11.83

2.7

2.5

21.99

23.16

2.53

1063

8994

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

102

476

2.15

11.79

2.0

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

2392

20788

1.19

11.77

4.5

4.1

91.62

92.40

0.84

2323

20263

(3028626) Oxygen [Partial pressure] in Capillary blood

384

2625

1.47

11.57

8.1

5.4

9.11

8.97

kpa

0.82

377

2553

(3020779) Urea [Moles/volume] in Serum or Plasma

853

6647

1.30

11.53

8.9

8.1

8.08

8.60

mmol/l

1.74

814

6377

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

563

4128

1.38

11.49

1.1

26.35

8.86

u/ml

0.32

(40758558) Short blood count panel - Blood

2500

21854

1.18

11.44

7.6

7.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1001

7984

1.27

11.28

3.4

2.9

1.71

1.73

0.24

904

7158

(3039000) Anion gap in Blood

249

1558

1.61

11.25

8.8

6.4

11.30

11.27

mmol/l

0.04

229

1382

(3018572) Chloride [Moles/volume] in Blood

249

1559

1.61

11.22

8.8

6.4

105.27

mmol/l

0.01

229

1383

(3011288) Drugs identified in Urine by Screen method

528

3852

1.38

11.11

3.4

3.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2303

20037

1.18

11.09

2.6

2.5

1788.02

3689.53

umol/l

3.17

2027

17860

(3020961) Endomysium IgA Ab [Titer] in Serum

679

5158

1.33

11.01

1.1

1.2

147.11

222.13

titre

0.44

153

(3023410) Appearance of Cerebral spinal fluid

173

992

1.75

10.90

2.0

2.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

832

6516

1.30

10.82

4.7

4.3

0.16

0.11

0.62

204

1882

(3023520) Reticulocytes [#/volume] in Blood

750

5803

1.31

10.68

3.0

2.7

70.86

70.02

e9/l

0.25

547

4259

(3013005) Retinol [Moles/volume] in Serum or Plasma

103

510

2.02

10.25

2.2

2.4

1.87

1.82

umol/l

0.23

484

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1571

13291

1.21

10.24

2.7

2.9

2.44

mmol/l

1.04

1351

11579

(3028707) Methadone [Presence] in Urine by Screen method

355

2451

1.46

10.21

3.1

2.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

712

5508

1.31

10.16

1.8

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2389

21021

1.17

9.87

3.9

11.15

9.53

mg/mmol

0.54

1533

13485

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

780

6134

1.29

9.83

4.3

3.7

1.23

mmol/l

0.45

681

5375

(3000570) Elastase.pancreatic [Mass/mass] in Stool

333

2293

1.46

9.73

1.5

1.4

282.92

286.55

ug/g

0.11

177

1283

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

589

4469

1.33

9.66

1.6

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

200

1242

1.62

9.40

1.5

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

490

3639

1.36

9.28

12.6

10.1

24.42

24.23

mmol/l

0.76

468

3539

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

418

2.06

9.05

2.8

2.5

55.65

51.67

umol/l

0.54

373

(3048689) Calprotectin [Mass/mass] in Stool

1468

12479

1.20

9.02

2.5

141.55

123.96

ug/g

0.67

1169

9881

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

920

7469

1.25

8.90

2.5

0.22

g/l

0.03

863

6990

(3012516) Albumin [Mass/volume] in Urine

2275

20090

1.16

8.84

3.3

441.66

419.99

mg/l

0.07

1475

12900

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

498

1.95

8.78

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

672

5263

1.29

8.76

2.0

1.8

1.28

1.29

g/l

0.02

629

4858

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

356

2541

1.41

8.60

9.0

6.7

1.35

1.33

mg/l

0.23

329

2399

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

715

5661

1.28

8.56

1.3

43.61

50.38

au/ml

0.29

289

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

769

6143

1.27

8.55

2.4

2.3

17.09

22.41

au/ml

1.36

550

(3020630) Protein [Mass/volume] in Serum or Plasma

693

5473

1.28

8.46

2.4

2.5

66.52

66.73

g/l

0.31

643

5038

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

379

2745

1.39

8.42

1.6

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

573

4421

1.31

8.37

6.3

5.5

24.10

24.02

mmol/l

0.29

563

4359

(3021387) Prolactin [Units/volume] in Serum or Plasma

584

4520

1.30

8.34

1.8

1.6

342.43

313.20

mu/l

0.92

520

4070

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

461

1.95

8.23

1.5

1.2

69.00

68.68

0.01

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

224

1477

1.52

8.17

4.0

3.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

695

5518

1.27

8.14

3.4

2.9

160.24

168.26

ng/l

0.19

614

4960

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8717

84327

1.16

8.06

4.6

4.2

2.78

2.83

mmol/l

5.87

8147

78988

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.74

8.00

5.4

5.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1475

12679

1.18

7.95

3.2

2.8

3.37

3.07

e6/l

0.42

806

6707

(3036180) Methadone [Presence] in Urine

118

670

1.76

7.83

2.0

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

469

3556

1.33

7.78

1.2

1.19

1.15

u/ml

0.02

305

(3013512) EKG study

2327

20752

1.15

7.78

3.6

3.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

718

5768

1.26

7.63

2.6

2.3

4495.18

5900.27

u/l

0.76

272

2282

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

308

2196

1.41

7.54

1.9

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8607

83280

1.15

7.53

4.2

3.9

4.65

4.72

mmol/l

11.18

8083

78458

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.57

7.51

5.6

5.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

541

4207

1.30

7.48

5.3

4.0

130.62

130.36

g/l

0.10

529

4105

(3017446) Testosterone [Moles/volume] in Serum or Plasma

733

5926

1.25

7.37

2.3

2.1

12.03

11.93

nmol/l

0.12

666

5355

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

869

7167

1.23

7.27

1.2

131.10

147.47

iu/ml

0.63

339

2712

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8545

82698

1.15

7.21

4.1

3.9

1.45

1.47

mmol/l

6.94

7986

77610

(3030981) Hyaline casts [#/volume] in Urine by Automated count

499

3870

1.30

7.06

3.0

2.6

0.25

0.27

e6/l

0.06

490

3747

(3000494) Fungus identified in Specimen by Culture

1129

9589

1.19

6.96

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

422

3207

1.32

6.93

4.4

3.6

25.23

25.19

mmol/l

0.09

412

3100

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

337

2478

1.37

6.89

1.2

1.3

13.83

39.48

u/ml

2.49

160

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

146

911

1.60

6.86

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

184

2.39

6.76

1.7

1.6

—

(3008295) Osmolality of Serum or Plasma

136

837

1.63

6.76

1.8

1.6

286.84

281.75

mosm/kgh2o

1.79

114

648

(3049233) Organic acids panel - Urine

4.08

6.76

1.4

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

424

1.89

6.70

3.6

2.4

134.51

179.49

umol/l

0.84

215

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.99

6.57

7.1

7.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

151

962

1.57

6.52

7.9

6.8

11.41

11.17

mg/l

0.23

142

896

(1616796) Gas panel - Central venous blood

241

1692

1.43

6.50

4.9

3.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

486

1.81

6.48

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

164

2.44

6.43

3.9

2.3

—

(3012501) Base excess in Blood by calculation

245

1729

1.42

6.42

5.7

4.0

2.48

2.39

mmol/l

0.20

167

1132

(3013290) Carbon dioxide [Partial pressure] in Blood

245

1730

1.42

6.40

5.7

4.0

5.06

5.01

kpa

0.52

240

1705

(3027315) Oxygen [Partial pressure] in Blood

246

1740

1.42

6.37

5.5

4.0

8.92

8.81

kpa

0.44

241

1714

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

969

8185

1.20

6.35

4.2

4.4

250.51

241.75

u/l

0.50

912

7767

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8238

79729

1.13

6.25

3.7

3.5

1.28

1.27

mmol/l

0.64

7668

74361

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

308

2272

1.36

6.22

1.2

1.3

9.02

9.91

u/ml

0.08

356

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

304

2240

1.36

6.18

1.2

1.3

4.78

5.35

u/ml

0.10

213

(3004588) Protein electrophoresis panel - Serum or Plasma

546

4359

1.26

6.17

2.3

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

361

2739

1.32

6.05

1.7

1.8

0.23

g/l

0.06

332

2603

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

370

2819

1.32

6.02

1.7

1.19

1.18

g/l

0.38

342

2682

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

249

1784

1.40

6.02

3.9

3.6

57.89

56.84

0.66

249

1784

(36660697) Celiac disease serology panel - Serum

961

8151

1.19

6.02

1.2

—

(3010421) pH of Blood

276

2015

1.37

5.96

5.4

3.9

7.42

0.06

254

1841

(3042517) Benzodiazepines panel - Urine

153

2.41

5.87

3.2

2.5

—

(3023419) Bacteria identified in Sputum by Culture

149

971

1.54

5.87

2.6

2.9

—

(3022145) Colonoscopy Study observation

1043

8929

1.18

5.87

1.3

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

107

644

1.66

5.87

12.3

11.7

0.63

0.60

mmol/l

0.85

102

590

(3010838) Calcium [Moles/time] in 24 hour Urine

199

1379

1.45

5.80

2.1

1.9

5.60

5.13

mmol/24h

1.21

186

1224

(3026389) Candida sp identified in Specimen by Organism specific culture

191

1314

1.46

5.79

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

3936

0.75

5.73

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

1301

1.46

5.72

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

3932

0.75

5.70

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

207

1451

1.43

5.69

1.9

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

163

1091

1.50

5.68

1.5

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

202

1412

1.43

5.64

1.3

1.2

467.50

137.04

titre

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

334

2534

1.32

5.63

2.8

2.0

2.40

2.42

ug/l

0.01

287

2244

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

264

1934

1.37

5.61

1.2

1.3

38.47

44.13

u/ml

0.24

189

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

297

3911

0.75

5.60

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

249

1808

1.38

5.59

1.2

1.3

7.42

3.99

u/ml

0.33

129

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1099

9487

1.17

5.59

2.9

3.1

7.81

7.39

umol/l

0.23

921

8135

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

351

2685

1.31

5.58

1.8

1.6

208.81

350.27

titre

0.53

113

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

299

3924

0.75

5.51

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

424

3332

1.28

5.50

1.7

1.6

32.61

11.31

u/ml

—

105

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1396

12290

1.15

5.47

2.0

1.7

1.40

0.15

1253

11003

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

184

2.22

5.44

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

177

1216

1.46

5.43

1.5

1.6

77.13

64.58

mmol/l

2.45

142

971

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

256

1877

1.37

5.42

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

369

2857

1.30

5.38

1.1

2.32

6.92

u/ml

3.49

401

(3023511) Choriogonadotropin [Units/volume] in Urine

388

3030

1.29

5.30

1.4

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

253

1860

1.36

5.28

4.8

3.5

24.31

24.51

mmol/l

0.35

248

1822

(1001926) Buprenorphine [Presence] in Urine by Screen method

545

4437

1.24

5.23

2.7

2.2

—

(40768804) Tissue Pathology biopsy report

3638

33959

1.10

5.21

2.0

—

(3008898) HLA-B27 [Presence]

464

3713

1.26

5.20

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

234

2.05

5.19

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

2859

26376

1.11

5.16

2.5

2.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

120

769

1.56

5.15

3.2

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

455

3638

1.26

5.13

1.4

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

360

2804

1.29

5.04

4.1

3.4

3.38

3.47

g/l

0.61

343

2662

(3023323) Follitropin [Units/volume] in Serum or Plasma

702

5885

1.20

5.03

1.5

1.4

26.15

25.53

iu/l

0.19

574

5001

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

237

2.02

5.02

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1418

12571

1.14

5.02

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

328

1.86

4.99

1.1

88.70

175.18

ng/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

122

2.45

4.98

1.5

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

160

1102

1.45

4.89

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

641

5347

1.21

4.85

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

219

1599

1.37

4.81

2.8

2.4

16.90

16.68

0.32

107

799

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

247

1838

1.35

4.81

1.8

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

288

2192

1.32

4.81

2.1

9.95

10.70

mg/l

0.98

270

2057

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

276

1.92

4.79

3.4

2.7

29.31

28.83

umol/l

0.11

199

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

333

4222

0.78

4.78

1.4

1.5

—

(3017704) Immunofixation for Urine

319

1.85

4.76

1.2

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

534

1.65

4.76

1.9

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

236

1.99

4.72

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

333

2592

1.29

4.71

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

335

2613

1.29

4.67

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.78

4.67

2.1

2.4

—

(3037756) Immunofixation for Serum or Plasma

174

1229

1.42

4.66

1.4

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

365

1.78

4.65

2.9

2.4

159.70

155.81

nmol/l

0.14

315

(3009214) Lutropin [Units/volume] in Serum or Plasma

440

3554

1.24

4.58

1.7

1.5

9.37

9.22

u/l

0.08

360

2828

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

239

1.96

4.57

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

226

1676

1.35

4.53

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

226

1677

1.35

4.51

1.3

—

(1002224) Polysomnography panel

473

3860

1.23

4.48

1.1

—

(3011412) CD3 cells [#/volume] in Blood

143

983

1.46

4.46

3.1

2.7

1.26

1.29

e9/l

0.17

129

843

(42529406) Shigella sp [Presence] in Stool by Culture

335

2631

1.28

4.44

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

105

2.47

4.41

1.5

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

171

1221

1.40

4.34

2.4

1.9

1.62

1.70

mmol/l

0.78

166

1194

(3047352) Trisomy 18 risk [Likelihood] in Fetus

244

3172

0.76

4.29

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

512

1.62

4.25

1.3

1.5

4.95

6.11

u/l

1.73

443

(3051593) INR in Capillary blood by Coagulation assay

247

1.90

4.18

8.8

10.7

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

2.28

1.90

mg/l

0.14

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

1.39

2.41

mg/l

0.58

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

2.20

4.25

mg/l

1.59

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

1.09

2.60

mg/l

1.51

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

0.35

1.31

mg/l

2.76

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

2.36

2.57

mg/l

0.05

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

0.53

1.89

mg/l

2.25

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

0.91

1.42

mg/l

0.51

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

114

2.36

4.18

1.7

1.95

3.66

mg/l

0.81

(21494755) Public health laboratory ask at order entry panel

961

10876

0.87

4.17

1.3

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

6.90

4.14

5.6

5.7

99.67

91.75

umol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

135

932

1.45

4.14

1.4

8.02

7.86

mmol/l

0.16

130

911

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

327

1.77

4.14

1.4

1.5

14.82

14.51

pmol/l

0.21

273

(3013139) Helicobacter pylori Ag [Presence] in Stool

676

5753

1.18

4.14

1.2

—

(3036489) Thrombin time

418

3399

1.23

4.13

3.1

2.7

21.38

21.46

0.11

366

2934

(40757494) Bilirubin.total [Moles/volume] in Blood

425

1.67

4.10

1.9

2.6

80.98

73.41

umol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

315

2482

1.27

4.10

1.2

1.3

127.50

118.28

titre

0.07

238

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

113

755

1.50

4.09

2.9

2.8

436.72

528.95

e6/l

1.94

607

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

221

1.94

4.09

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

253

3251

0.77

4.09

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

125

853

1.47

4.08

1.5

1.6

52.79

53.79

0.10

537

(3020191) Ethanol [Moles/volume] in Serum or Plasma

116

780

1.49

4.08

1.7

1.5

1.39

1.33

promille

0.16

582

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

888

7740

1.16

4.02

2.4

2.5

32.92

43.19

u/l

0.94

746

6636

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

167

1206

1.39

4.00

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

246

3161

0.77

3.98

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

358

2876

1.25

3.96

1.6

5.24

3.66

iu/ml

0.11

616

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.54

3.95

1.1

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.47

3.92

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

303

2392

1.27

3.90

3.1

2.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

118

2.28

3.89

1.7

1.27

2.06

mg/l

0.35

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.49

3.84

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

177

1301

1.36

3.82

3.9

2.9

—

(3034770) Mitochondria Ab [Titer] in Serum

307

2438

1.26

3.78

1.2

1.3

920.00

1030.74

titre

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.52

3.76

1.0

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

138

978

1.41

3.72

1.7

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

515

1.57

3.71

3.2

2.8

12.75

12.50

0.05

494

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

138

979

1.41

3.70

1.7

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

2.01

3.69

6.6

6.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

223

1708

1.31

3.66

2.3

2.2

132.35

131.02

g/l

0.38

175

1256

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2387

22152

1.09

3.65

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

109

743

1.47

3.63

3.0

2.8

0.23

0.22

e9/l

0.09

609

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

833

9425

0.87

3.62

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

119

826

1.44

3.60

2.6

2.1

32.36

32.65

0.26

119

817

(3028433) Virus identified in Specimen by Culture

305

1.73

3.58

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

201

1525

1.32

3.54

1.6

0.62

0.73

g/l

1.29

144

1161

(3033923) Metanephrine [Moles/time] in 24 hour Urine

143

2.09

3.54

1.2

1.1

0.65

0.72

umol/24h

0.46

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.39

3.52

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

101

683

1.48

3.51

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

179

1339

1.34

3.48

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

179

1340

1.34

3.47

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

662

1.48

3.43

1.5

1.6

32.60

33.68

0.10

405

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

368

3021

1.22

3.39

4.2

3.3

93.90

93.33

0.18

348

2910

(3036782) Glucose [Moles/volume] in Pleural fluid

544

1.52

3.36

1.5

1.4

6.11

6.30

mmol/l

0.33

508

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

125

889

1.41

3.34

1.5

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

154

1134

1.36

3.34

1.2

1.3

66.50

53.61

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

239

1874

1.28

3.31

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

203

1.87

3.29

1.6

1.3

239.67

115.03

nmol/l

0.86

148

(3016879) Cocaine [Presence] in Urine

614

5293

1.17

3.27

2.6

2.1

—

(44813793) Dust mix specific IgE antibody measurement

109

760

1.43

3.26

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

128

2.10

3.25

1.4

1.6

—

(3017732) Neutrophils [#/volume] in Blood

698

6081

1.15

3.23

2.5

2.6

4.57

4.60

e9/l

0.04

572

5098

(3010144) Erythrocytes [#/volume] in Synovial fluid

655

1.46

3.22

1.4

41124.30

79742.07

e6/l

0.68

461

(3028300) Cannabinoids [Presence] in Urine

662

5750

1.16

3.20

2.6

2.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

129

2.09

3.19

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

177

1.92

3.19

1.2

1.3

50.47

39.76

0.70

116

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

494

4195

1.18

3.18

1.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

656

5700

1.16

3.16

2.5

2.1

—

(3027008) Opiates [Presence] in Urine

660

5739

1.16

3.15

2.5

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

177

1345

1.32

3.13

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

341

1.64

3.12

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

137

1003

1.37

3.11

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

317

2590

1.23

3.09

1.7

42.12

40.58

nmol/l

0.51

308

2528

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.79

3.06

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

421

1.57

3.05

1.5

1.4

625.50

492.94

mu/l

0.56

402

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

430

1.56

3.02

1.4

74.57

72.77

0.50

411

(3006653) Thiamine [Moles/volume] in Blood

391

1.58

3.01

1.1

1.4

134.48

134.35

nmol/l

0.01

391

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

278

1.69

2.94

2.0

1.7

0.17

0.20

nmol/l

0.31

199

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

127

2.04

2.93

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

242

1933

1.25

2.92

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1897

17593

1.09

2.91

4.6

4.3

2.31

2.90

ug/l

0.95

1712

15960

(3000475) Leukocytes [#/volume] in Synovial fluid

217

1712

1.27

2.91

1.6

11789.02

13075.28

e6/l

0.19

176

1242

(3024928) Oxygen saturation in Venous blood

202

1581

1.28

2.89

6.5

4.8

—

(3000060) B lymphocytes [#/volume] in Blood

421

1.54

2.84

3.3

2.7

181.22

280.24

e6/l

1.22

248

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

332

2758

1.21

2.78

3.4

3.2

170.09

179.51

1.37

314

2629

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1871

17379

1.09

2.77

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

892

7994

1.12

2.72

2.0

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

694

6128

1.14

2.69

2.9

2.5

69.22

71.72

ml/min/173m2

0.74

265

2309

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

567

6440

0.87

2.67

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

225

1804

1.25

2.66

5.9

6.0

227.97

1666.47

iu/ml

0.86

230

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

559

1.45

2.63

1.7

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

617

1.42

2.63

1.2

74.17

68.26

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.13

2.62

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

181

1418

1.28

2.61

3.0

3.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

319

1.60

2.61

1.8

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

1008

1.33

2.61

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

201

1595

1.26

2.61

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

261

2132

1.23

2.61

1.5

21.08

18.42

u/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

216

1730

1.25

2.59

1.8

1.9

184.31

191.24

pmol/l

0.40

204

1646

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

255

2080

1.23

2.59

2.3

0.94

0.78

g/l

0.27

225

1825

(3042631) Mycobacterium sp identified in Specimen

116

857

1.35

2.55

2.4

2.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

177

1.80

2.55

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

621

1.42

2.55

1.2

59.08

40.63

u/ml

—

(3036005) Urine sediment comments by Light microscopy Narrative

7.12

2.54

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

232

1880

1.23

2.52

3.1

3.2

30.37

50.30

mg/l

1.76

175

1527

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

178

1.79

2.51

1.3

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.41

2.51

1.1

10.87

14.77

u/l

0.20

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

458

3949

1.16

2.51

2.1

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2315

1.21

2.50

2.2

2.81

2.94

g/l

1.53

255

2108

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

440

3784

1.17

2.50

2.5

2.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

284

1.62

2.50

1.3

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

232

1882

1.23

2.49

3.2

39.35

80.58

mg/l

0.76

174

1528

(3027944) Amphetamines [Presence] in Urine

640

5655

1.14

2.48

2.5

2.0

—

(3019977) pH of Arterial blood

371

1.53

2.48

2.3

2.9

7.42

7.43

0.35

121

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

244

1993

1.22

2.46

1.6

1.5

105.70

111.65

u/ml

0.62

365

(43055514) Macroprolactin [Presence] in Serum or Plasma

332

1.56

2.46

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

634

1.40

2.46

1.2

—

43.64

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.31

2.45

1.1

1.2

1.66

1.62

umol/24h

0.08

(3035947) Staphylolysin Ab [Units/volume] in Serum

372

1.53

2.45

1.1

2.80

3.85

iu/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

363

3079

1.18

2.45

1.8

1.44

1.48

g/l

0.29

314

2646

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.80

2.45

2.4

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

644

5701

1.13

2.43

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

302

1.59

2.42

3.4

4.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

166

1.80

2.41

1.6

1.4

—

(3002256) Pathology report gross observation

1147

10494

1.10

2.39

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

673

7499

0.89

2.38

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

262

2164

1.21

2.38

2.5

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

116

868

1.34

2.38

9.5

12.6

6.81

7.27

mmol/l

0.85

715

(3037121) Protein [Mass/volume] in Urine

338

2859

1.18

2.37

3.8

3.6

0.26

0.36

g/l

1.74

170

1333

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

123

929

1.32

2.37

1.8

1.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

658

1.38

2.32

2.7

3.1

99.63

96.84

0.36

616

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

224

1827

1.23

2.31

3.0

3.2

7.04

1.91

ratio

0.42

169

(3049717) Cytology report of Urine Cyto stain

265

2198

1.21

2.31

2.1

2.5

—

(3035880) pH of Pleural fluid

298

1.57

2.31

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

133

1020

1.30

2.30

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

255

2110

1.21

2.29

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

419

1.48

2.29

1.5

11.53

12.36

u/l

0.60

406

(3017509) Phencyclidine [Presence] in Urine

140

1.85

2.28

1.5

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

112

1.96

2.27

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

687

1.37

2.26

1.2

1.3

1.28

3.48

u/ml

2.60

385

(3003338) MCHC [Mass/volume]

8040

78783

1.07

2.25

19.6

15.2

332.96

332.95

g/l

0.03

7988

78186

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

459

3997

1.15

2.24

1.4

1.3

201.63

225.26

miu/ml

0.67

179

1946

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

285

1.58

2.23

1.6

1.2

15.90

18.03

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

571

1.40

2.22

1.2

—

(4062490) Immunoglobulin typing, IgG

128

983

1.30

2.21

1.7

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

441

5022

0.87

2.21

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

100

1.99

2.18

1.2

1.5

65.27

59.57

0.22

(3027135) IgG subclass 1 [Mass/volume] in Serum

128

986

1.30

2.17

1.6

1.3

6.72

6.54

g/l

0.23

693

(3044927) Protein electrophoresis panel - Urine

616

1.38

2.16

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

499

1.42

2.16

3.3

2.7

47.10

42.20

1.54

266

(3003327) Ova and parasites identified in Stool by Light microscopy

396

3423

1.16

2.15

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1095

10052

1.09

2.14

2.1

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

1.65

2.12

2.7

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

1.65

2.12

2.7

3.2

—

(3022621) pH of Urine by Test strip

599

5332

1.13

2.11

3.0

2.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

880

8001

1.10

2.11

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

662

1.36

2.10

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

257

2149

1.20

2.09

5.8

4.4

0.36

0.33

u/ml

0.72

141

1205

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

109

1.92

2.07

8.0

9.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

225

1861

1.21

2.06

2.2

0.01

0.02

g/l

0.61

209

1725

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

665

1.35

2.05

1.4

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

127

986

1.29

2.05

1.6

1.3

3.04

2.82

g/l

0.52

693

(3024139) IgG subclass 3 [Mass/volume] in Serum

127

986

1.29

2.05

1.6

1.3

0.42

0.38

g/l

0.56

689

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.07

2.04

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

256

2146

1.19

2.04

1.7

1.4

22.33

12.46

iu/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

256

2148

1.19

2.02

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

132

1.81

2.00

1.0

1.12

0.03

u/ml

0.46

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

465

1.42

2.00

1.3

1.5

15.20

19.63

u/ml

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

2270

1.19

1.99

2.2

9.91

10.22

g/l

0.65

243

2048

(3000012) Reticulocyte production index

114

876

1.30

1.99

2.6

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2446

1.18

1.98

2.2

3.62

3.65

g/l

0.10

263

2240

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

790

1.31

1.98

1.6

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2447

1.18

1.97

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

226

1880

1.20

1.97

2.6

2.5

7.04

6.79

umol/l

0.07

154

1404

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

384

1.46

1.97

1.3

15.27

12.19

u/l

0.64

359

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

360

1.47

1.95

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2450

1.18

1.95

2.2

7.08

7.37

g/l

2.27

263

2241

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

328

1.49

1.94

3.5

3.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

256

1.56

1.94

3.0

2.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

3.74

1.92

1.0

1.4

5711.67

3303.07

umol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1898

1.20

1.89

2.1

39.06

38.04

g/l

1.91

202

1691

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.30

1.86

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

151

1.72

1.84

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

192

1587

1.21

1.81

1.1

2.34

3.64

u/ml

1.09

783

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1494

14001

1.07

1.78

4.1

3.8

22.13

21.70

0.48

639

6079

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6911

67610

1.05

1.76

3.5

3.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

336

1.45

1.75

1.1

—

(3002619) Bacteria identified in Specimen by Culture

184

1.63

1.75

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

168

1377

1.22

1.74

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

711

1.31

1.73

2.9

2.8

758.00

758.33

e6/l

0.00

692

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.72

1.0

1.1

—

(3032641) Amino acids panel - Urine

2.66

1.71

1.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

214

1800

1.19

1.70

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

125

996

1.25

1.69

1.9

1.6

42.17

29.58

iu/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

1.61

1.69

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

610

1.33

1.69

1.7

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

671

1.31

1.68

1.5

1.4

10.95

11.53

umol/l

0.38

642

(3034891) Synovial lining cells/100 cells in Synovial fluid

348

1.43

1.67

1.3

1.6

2.00

4.14

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.15

1.65

1.2

2.2

—

1702.50

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

291

0.55

1.65

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

291

0.55

1.65

3.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

241

2054

1.17

1.65

1.7

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

190

1587

1.20

1.64

1.5

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

358

1.42

1.63

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

442

1.38

1.63

1.5

1.6

4.92

4.35

nmol/l

0.06

357

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

160

1922

0.83

1.62

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

1398

1.21

1.62

5.3

3.7

517.70

896.34

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

109

860

1.27

1.62

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

616

1.31

1.59

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

616

1.31

1.59

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

616

1.31

1.59

1.5

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.83

1.59

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.83

1.59

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

143

1.67

1.58

1.2

136.32

91.24

mg/l

0.12

106

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

505

1.34

1.57

1.1

1563.64

1516.90

miu/ml

0.11

505

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1959

18602

1.06

1.57

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

1206

1.22

1.55

1.4

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

733

1.28

1.54

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

734

1.28

1.53

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

104

823

1.26

1.52

1.2

138.52

65.04

u/l

1.02

746

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

735

1.28

1.52

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

727

1.28

1.51

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

527

1.33

1.49

4.0

3.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

728

1.28

1.49

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

737

1.27

1.49

2.5

2.2

4.11

4.02

mmol/l

1.07

727

(3003434) Protein [Mass/volume] in Pleural fluid

737

1.27

1.49

1.6

1.5

34.20

33.28

g/l

0.28

670

(3019225) pH of Specimen

780

7186

1.09

1.48

4.1

4.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

729

1.27

1.48

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

177

1486

1.19

1.48

1.8

2.0

1.20

6.91

titre

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

1532

1.19

1.47

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

101

801

1.26

1.46

3.5

3.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

283

1.45

1.46

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

488

1.33

1.43

1.5

1.6

7.04

6.11

u/l

0.26

404

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.72

1.42

5.3

1.5

1.55

2.94

mu/l

—

(3006270) Folate [Moles/volume] in Blood

654

1.28

1.42

1.2

1.1

387.64

386.26

nmol/l

0.02

584

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1695

1.17

1.42

2.3

2.2

0.00

g/l

-0.00

184

1583

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2108

20121

1.05

1.41

2.5

2.2

—

(3044941) Cell count panel - Synovial fluid

136

1121

1.21

1.40

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

106

851

1.24

1.40

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

379

1.37

1.39

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

420

3770

1.11

1.38

1.9

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

737

1.26

1.37

2.5

2.2

105.76

105.38

mmol/l

0.39

727

(3000492) Spirometry study

956

8912

1.08

1.36

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

119

1.68

1.35

5.5

4.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

416

1.34

1.0

756.88

758.91

ng/l

0.01

286

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

135

1.62

1.33

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

178

1512

1.18

1.33

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

661

1.27

1.33

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

109

885

1.23

1.31

1.8

2.0

13.13

25.69

mg/l

4.69

233

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

200

1717

1.16

1.31

2.3

2.2

0.00

g/l

0.50

184

1587

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

375

1.36

1.30

1.7

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

601

1.28

1.30

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

299

1.40

1.30

1.6

2.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.49

1.29

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.09

1.29

1.3

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

168

1.54

1.29

1.5

2.39

2.92

0.13

143

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

419

1.33

1.28

1.0

41.17

44.04

ng/l

0.19

293

(3020911) Cortisol [Moles/time] in 24 hour Urine

342

1.37

1.28

1.3

75.27

106.11

nmol/24h

0.88

342

(3012989) Citrate [Moles/time] in 24 hour Urine

2.77

1.28

1.6

1.5

1.36

1.94

mmol/24h

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

217

1.47

1.28

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

201

1732

1.16

1.27

4.0

3.2

23.72

26.37

mg/l

0.46

130

1060

(4035726) Immunohistochemistry procedure

722

6682

1.08

1.26

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

336

1.37

1.24

1.6

1.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.39

1.23

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

379

1.34

1.23

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

102

830

1.23

1.22

1.2

2.55

2.53

u/ml

0.00

355

(3019420) Tryptase [Mass/volume] in Serum or Plasma

545

1.28

1.22

1.7

1.4

6.21

6.71

ug/l

0.26

483

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

250

2195

1.14

1.22

1.4

226.79

255.42

u/ml

1.23

152

1353

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

195

1.48

1.21

5.3

6.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

100

1.69

1.21

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

537

1.28

1.21

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

329

1.36

1.21

2.9

2.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

441

1.31

1.21

1.2

35.93

13.91

u/ml

0.28

286

(3027874) Urate [Moles/volume] in Urine

2.62

1.21

1.0

1.92

1.78

mmol/l

—

(3022689) Creatine [Moles/volume] in Urine

220

1.45

1.21

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

407

1.32

1.20

3.9

2.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

262

2311

1.13

1.20

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

735

1.24

1.18

2.2

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

754

1.23

1.17

2.3

2.4

—

(3004451) EKG impression Narrative

306

1.37

1.16

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

133

1120

1.19

1.14

1.5

1.6

32.62

71.27

mu/l

3.54

122

1007

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

676

1.24

1.14

1.3

1.4

1.54

1.43

nmol/l

0.43

612

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

388

3513

1.10

1.13

1.5

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

385

1.32

1.13

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

245

2162

1.13

2.8

2.4

—

(3016038) Potassium [Moles/volume] in Urine

508

1.28

1.12

1.5

34.66

35.03

mmol/l

0.04

448

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

412

0.70

1.12

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.84

1.12

1.3

5.1

—

(3045788) Cell count panel - Pleural fluid

535

1.27

1.12

1.6

1.5

—

(40768443) Skin Pathology biopsy report

386

3498

1.10

1.11

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

111

1.62

1.10

7.3

6.3

2.98

2.09

mg/l

0.98

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

422

1.30

1.10

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

535

5760

0.92

1.09

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1130

10686

1.06

1.09

1.7

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

493

1.27

1.09

1.4

1.3

763.23

370.35

u/l

0.69

475

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.94

1.08

1.1

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.94

1.08

1.5

2.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

437

3992

1.09

1.08

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

285

1.36

1.08

2.2

2.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

202

1767

1.14

1.08

1.5

1.3

22.43

24.25

u/l

0.33

162

1457

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

415

1.30

1.07

1.0

315.24

325.95

ng/l

0.09

295

(3033705) Calcium.ionized [Moles/volume] in Venous blood

718

1.22

1.06

2.6

2.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

691

1.23

1.06

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

597

5530

1.08

1.06

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1219

12749

0.95

1.06

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

185

1.46

1.06

4.3

4.9

1.19

1.20

mmol/l

0.19

176

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

381

1.31

1.06

1.6

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

381

1.31

1.06

1.6

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

602

1.24

1.06

1.6

1.4

61763.80

64471.11

e6/l

0.04

352

(3020876) Protein [Mass/time] in 24 hour Urine

755

1.22

1.05

2.6

2.4

1.29

1.49

g/24h

0.24

388

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

399

1.30

1.05

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.92

1.05

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

189

1650

1.14

1.04

3.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

121

1.57

1.03

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

1040

1.18

1.03

1.2

1.4

369.04

389.85

pmol/l

0.11

109

911

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.79

1.03

1.0

1.2

—

(3012441) Differential panel - Pleural fluid

569

1.24

1.02

1.7

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

677

1.22

1.02

2.3

2.9

102.89

56.74

mg/l

0.33

504

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

217

1916

1.13

1.02

1.4

1.5

0.39

0.44

nmol/l

0.28

159

1531

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.83

1.01

1.1

9.68

9.45

mg/l

0.03

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

1.01

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

224

1983

1.13

1.01

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

714

1.22

1.01

1.3

—

(3004775) Volume in Urine collected for unspecified duration

526

1.25

1.00

2.3

743.00

632.00

1.29

378

(3051101) Glucose [Moles/volume] in Cord blood

109

0.46

1.00

2.2

6.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

459

0.74

1.00

1.7

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.68

1.00

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

368

1.30

0.99

5.1

5.5

3286.22

70.15

mg/l

0.50

279

(3027456) Digoxin [Moles/volume] in Serum or Plasma

117

990

1.18

0.98

2.7

3.1

0.83

0.81

nmol/l

0.25

753

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

147

1.49

0.98

2.2

7.65

7.28

mmol/l

0.12

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

469

0.74

0.98

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2370

22886

1.04

0.98

2.1

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

890

1.19

0.98

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

519

1.25

0.98

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.97

0.0

1.1

—

66.65

—

(3039443) Prostate specific Ag panel - Serum or Plasma

106

1248

0.84

0.97

1.5

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

215

1.39

0.95

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

215

1.39

0.95

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

215

1.39

0.95

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

152

1318

1.15

0.95

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

207

1.40

0.94

3.1

2.3

1.17

1.66

mmol/l

0.92

156

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

303

2742

1.10

0.94

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

199

1.40

0.93

1.7

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

172

1507

1.14

0.93

1.3

3.59

3.70

u/ml

0.03

514

(3023199) Leukocytes [#/volume] in Pleural fluid

676

1.21

0.93

1.6

1.4

4170.45

2257.53

e6/l

0.78

493

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

302

1.32

0.93

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

302

1.32

0.93

2.2

2.4

140.74

116.13

ng/l

0.62

198

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

392

3598

1.09

0.91

1.5

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

167

1.43

0.90

1.2

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

134

1.49

0.90

4.5

3.5

6.95

4.11

0.35

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

743

1.19

0.89

1.1

8.88

8.45

iu/ml

0.06

175

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

753

1.19

0.89

1.2

224.55

196.94

titre

0.09

147

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

464

1.25

0.88

1.3

1.2

18.53

21.32

u/l

0.22

400

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

663

1.20

0.87

2.7

2.8

—

(3045424) Erythrocytes [Presence] in Urine

159

1394

1.14

0.87

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

447

1.25

0.87

25.8

27.0

146.39

123.72

ug/l

0.35

375

(3038071) Oxygen [Partial pressure] in Mixed venous blood

177

1.41

0.86

4.7

6.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

111

1.53

0.86

5.6

7.7

—

(3003694) ABO and Rh group [Type] in Blood

2793

27123

1.04

0.86

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

169

1.42

0.85

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.71

0.85

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

165

1854

0.88

0.84

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.77

0.84

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.77

0.84

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

120

1.50

0.84

4.6

7.0

62.00

72.29

0.63

100

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

120

1.50

0.84

2.4

4.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

255

2306

1.10

0.83

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

649

1.20

0.83

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

104

1.53

0.83

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

595

1.21

0.82

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

179

1.39

0.82

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

179

1.39

0.82

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

179

1.39

0.82

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

179

1.39

0.82

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

317

2903

1.09

0.80

2.0

1.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.70

0.80

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

181

1611

1.12

0.80

2.4

2.3

81.09

110.04

ug/min

0.41

1018

(3016750) Collection duration of Urine

399

1.25

0.79

2.4

2.2

511.70

498.69

min

0.40

312

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.78

0.0

7.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

166

1854

0.89

0.78

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

481

1.22

0.78

1.4

1.2

123.19

84.44

u/l

0.71

422

(3042111) Morphology [Interpretation] in Bone marrow Narrative

126

1098

1.14

0.78

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1061

10128

1.05

0.77

2.8

0.81

0.73

ug/l

0.55

667

6180

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

601

1.19

0.76

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.76

0.76

1.2

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.73

1.2

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.99

0.72

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1576

15200

1.04

0.72

2.2

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

188

1690

1.11

0.72

1.7

2.2

0.88

0.79

nmol/l

0.98

160

1433

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.72

1.0

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

133

1.42

0.72

1.6

1.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

125

1.44

0.71

2.4

4.5

19.28

21.52

mg/l

0.32

120

(3040893) Potassium [Moles/volume] in Capillary blood

1.92

0.70

6.4

2.2

4.50

4.47

mmol/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

145

0.62

0.69

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

143

1.39

0.68

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.85

0.68

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.85

0.68

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

210

1907

1.10

0.67

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

135

1.40

0.67

1.3

1.2

2.73

340.88

ug/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.63

0.67

1.5

385.30

313.72

umol/24h

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

119

0.59

0.67

3.7

6.4

—

(3025577) Chromium [Mass/volume] in Blood

364

1.23

0.67

2.1

2.01

2.27

ug/l

0.21

310

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.62

0.66

1.7

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

284

2618

1.08

0.66

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.78

0.66

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

168

1511

1.11

0.66

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

365

1.23

0.65

2.4

10.17

9.39

mg/l

0.38

307

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.51

0.65

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

147

1314

1.12

0.65

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

285

1.26

0.64

1.0

9.79

9.14

mu/l

0.23

236

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

154

1.36

0.63

1.2

1.1

0.71

3.22

u/ml

0.54

(40762814) Titanium [Mass/volume] in Blood

1.47

0.63

2.4

2.3

3.08

4.46

ug/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

196

1783

1.10

0.62

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

624

1.17

0.62

1.1

1.06

1.05

ratio

0.26

216

(3011648) Oxygen content in Venous blood

672

1.16

0.61

6.2

5.7

12.10

11.21

1.39

672

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

596

0.84

0.61

1.4

1.3

1.59

1.55

g/l

0.35

596

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

359

3353

1.07

0.60

1.6

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.56

0.60

4.4

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

503

4752

1.06

0.59

2.5

3.1

47.40

44.98

u/ml

0.11

488

4585

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

122

1.39

0.58

1.3

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.50

0.58

1.1

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

236

1.27

0.58

1.0

3.97

3.34

kpa

0.35

197

(3000330) Specific gravity of Urine by Test strip

393

3689

1.06

0.58

3.3

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

307

0.78

0.56

1.3

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.48

0.56

1.0

1.1

0.00

2.13

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

148

0.67

0.55

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

1073

1.12

0.55

1.3

1.2

—

(40758358) Immune stain study

1.62

0.55

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

182

0.71

0.54

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

137

1505

0.91

0.54

1.1

0.10

0.48

u/ml

2.01

450

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.57

0.54

2.2

5.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

125

1124

1.11

0.53

1.4

1.3

17.84

35.43

u/l

2.88

118

984

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

422

1.18

0.52

1.9

1.6

2.15

3.14

u/field

0.45

311

(3004959) Base excess in Arterial cord blood by calculation

240

1.25

0.52

1.0

-2.19

-2.12

mmol/l

—

(3006598) pH of Arterial cord blood

240

1.25

0.52

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

240

1.25

0.52

1.0

6.73

7.40

kpa

1.10

202

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

358

1.20

0.52

1.1

95.12

92.55

0.29

158

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

349

1.20

0.52

1.1

1.2

91.53

91.35

0.01

157

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.49

0.51

1.2

1.1

8.30

8.35

mmol/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

154

1403

1.09

0.51

1.1

118.65

116.64

0.29

134

1275

(3027231) Wheat IgE Ab [Units/volume] in Serum

286

1.22

0.51

1.1

1.2

2.01

7.39

u/ml

0.77

257

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

152

1.31

0.51

1.4

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

350

1.20

0.50

1.1

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

126

1.34

0.50

1.4

17.60

14.06

nmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

875

1.12

0.48

1.3

1.4

—

titre

—

(3032868) Hemoglobin electrophoresis panel in Blood

101

1.38

0.48

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

132

1198

1.10

0.48

3.3

1.32

1.53

0.32

111

1081

(3029075) Extractable nuclear Ab panel - Serum

288

1.21

0.48

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

171

1.28

0.48

1.7

1.6

0.48

0.39

ug/l

0.28

112

(3029396) Erythrocyte agglutination [Presence] in Blood

387

0.82

0.48

3.3

3.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.52

0.48

1.7

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

371

1.18

0.47

2.0

3.34

2.91

ug/l

0.16

335

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

371

1.18

0.47

1.3

1.2

118.49

107.02

0.90

336

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

284

2661

1.06

0.47

1.1

1.62

2.69

u/ml

0.98

163

1443

(4146454) Self-monitoring of blood glucose

696

0.87

0.47

3.2

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

464

1.16

0.47

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

172

1.27

0.47

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

821

0.89

0.46

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

254

2375

1.07

0.46

1.1

4.79

6.21

u/ml

0.88

145

1355

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

159

1463

1.08

0.44

1.3

3.67

4.16

u/ml

0.39

652

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

655

1.13

0.44

1.2

1.4

174.43

184.54

pmol/l

0.22

655

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

207

0.77

0.43

1.1

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

115

1045

1.10

0.43

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

112

1017

1.10

0.42

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

112

1019

1.10

0.41

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

131

1.29

0.41

1.2

1.1

0.10

0.43

u/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

140

1.28

0.41

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

140

1.28

0.41

1.1

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

341

1.17

0.40

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

726

1.11

0.40

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.47

0.40

1.0

—

(40760410) HLA-B [Type] by High resolution

1.47

0.40

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.47

0.40

1.0

—

(40760409) HLA-A [Type] by High resolution

1.47

0.40

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.47

0.40

7.8

9.4

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.40

0.0

7.8

—

62.50

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

361

3769

0.95

0.40

1.7

1.6

4.31

3.92

mg/l

0.25

263

2709

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

1022

1.09

0.39

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

137

0.73

0.39

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

111

1013

1.09

0.39

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

132

1.28

0.39

1.2

1.3

—

(3013862) HLA-DP [Type]

1.42

0.39

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

473

1.14

0.39

1.1

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

232

1.20

0.38

1.3

1.6

10.64

8.71

ug/l

1.07

232

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.40

0.38

1.7

1.5

8.78

20.61

pmol/l

—

(3022670) pH of Venous cord blood

1.40

0.38

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

112

1025

1.09

0.38

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

524

0.87

0.37

7.7

6.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

233

1.20

0.37

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

233

1.20

0.37

1.2

1.1

65.80

70.14

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

351

3342

1.05

0.37

1.7

1.8

—

(4281824) Cell count and differential, peritoneal fluid

889

0.91

0.36

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

156

0.77

0.35

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

591

1.11

0.35

1.8

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

334

3183

1.05

0.35

2.0

1.9

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

108

1.29

0.34

1.3

1.1

5.65

10.01

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

153

1.24

0.34

1.2

1.1

0.24

1.55

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

221

0.81

0.34

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1019

0.92

0.34

1.6

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

300

2855

1.05

0.33

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

529

0.88

0.33

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

190

1.21

0.33

1.6

2.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

190

1.21

0.33

1.2

38.20

39.07

g/l

—

108

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

736

1.10

0.33

1.9

1.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.34

0.33

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

748

0.91

0.33

1.0

1.1

1.04

1.64

u/ml

0.31

251

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

367

1.14

0.33

1.6

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

154

1.23

0.33

3.4

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

307

2926

1.05

0.33

1.5

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

633

1.10

0.32

4.2

4.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

368

1.14

0.32

1.5

1.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

453

0.88

0.32

4.9

3.8

9.50

8.29

mg/l

0.49

360

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.30

0.31

10.0

10.7

5.53

5.67

mmol/l

0.08

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

128

1.25

0.31

1.7

—

(3047189) Immunofixation for 24 hour Urine

285

1.15

0.30

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

598

1.10

0.30

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

314

1.14

0.30

4.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

456

1.11

0.29

1.1

95.00

92.69

0.27

366

(3010370) Gastrin [Moles/volume] in Serum or Plasma

129

1.24

0.29

1.5

1.9

21.51

42.58

pmol/l

1.45

106

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

120

1.25

0.29

2.3

1.8

2.15

1.59

mg/l

0.63

100

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

460

0.89

0.29

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

111

1.26

0.29

1.0

1.2

1.87

1.78

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

647

0.91

0.28

1.5

—

(3015183) Erythrocyte sedimentation rate

521

0.90

0.28

1.2

—

(3007463) Buprenorphine [Presence] in Urine

1.29

0.28

11.5

4.9

—

(3051339) Copper [Moles/volume] in Blood

1.29

0.28

1.4

1.2

16.46

16.98

umol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

213

1.17

0.28

1.4

1.9

47471.00

14882.67

e6/l

0.45

121

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

681

6957

0.97

0.27

3.4

4.0

5.94

28.12

ug/l

3.34

522

5465

(3022475) Manganese [Moles/volume] in Blood

1.27

0.27

1.4

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

402

1.12

0.27

1.8

1.36

1.26

nmol/l

0.19

311

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

109

1016

1.07

0.27

1.1

93.72

94.83

0.15

957

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

261

1.15

0.26

2.6

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

1424

1.06

0.26

1.7

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.68

0.26

1.0

1.1

—

3.79

—

(3014891) Appearance of Pleural fluid

0.66

0.25

1.4

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

104

1.25

0.25

2.2

2.3

45.63

71.50

pmol/l

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.27

0.25

1.3

1.5

6.83

10.72

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

392

0.89

0.25

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.23

0.25

1.0

0.05

0.18

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

624

1.09

0.25

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

169

1.18

0.25

1.2

1.3

5.11

3.36

mmol/l

0.70

153

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

779

1.07

0.24

1.1

—

(3024471) HLA-A [Type]

328

0.88

0.24

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

401

0.89

0.24

1.2

1.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

380

0.89

0.24

1.0

14.75

14.47

u/ml

0.02

224

(3010937) Rubella virus Ab [Presence] in Serum

0.73

0.24

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.26

0.23

1.3

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

421

0.90

0.23

4.2

3.2

98.97

138.28

au/ml

—

(3048879) Bone marrow aspiration report

170

1.17

0.23

1.6

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

723

1.08

0.23

1.0

1.1

294.03

288.24

mg/l

0.31

658

(40768800) Prostate Pathology biopsy report

978

0.94

0.23

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

792

0.93

0.23

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

126

1190

1.06

0.22

1.1

1.49

g/l

0.03

115

1082

(3000285) Sodium [Moles/volume] in Blood

0.76

0.22

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

237

1.14

0.22

1.6

2.2

1779.00

3928.89

e6/l

0.28

170

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

332

1.11

0.22

1.2

116.63

110.31

0.51

299

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.26

0.21

1.1

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

895

9074

0.98

0.21

4.2

4.0

32.01

32.27

0.30

656

6491

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

6.7

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

121

1145

1.05

0.21

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

236

2435

0.96

0.20

3.0

3.5

662.57

2295.01

u/ml

0.71

198

2088

(3008401) Mugwort IgE Ab [Units/volume] in Serum

237

2280

1.04

0.20

1.1

1.15

1.30

u/ml

0.12

111

1108

(3014133) Dog dander IgE Ab [Units/volume] in Serum

180

1867

0.96

0.20

1.1

5.36

4.80

u/ml

0.10

958

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

174

1806

0.96

0.20

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

574

1.08

0.20

2.0

1.9

3.38

1.82

u/field

0.83

261

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.78

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

340.40

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.25

0.20

1.2

3.0

—

0.00

—

(3024263) Appearance of Synovial fluid

402

1.09

0.19

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

108

1.20

0.19

1.7

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

109

1033

1.05

0.18

2.4

2.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.13

0.18

1.0

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

365

1.09

0.18

1.2

0.35

0.30

g/l

1.64

297

(3026692) Albumin [Mass/volume] in Peritoneal fluid

165

1.15

0.18

1.4

1.5

13.35

12.34

g/l

—

123

(40765089) Chromosome analysis panel - Blood by G-banded

452

1.08

0.18

1.1

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.20

0.18

1.1

—

4.03

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

762

1.06

0.18

1.5

1.3

5.37

5.33

umol/l

0.03

698

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

100

1.20

0.17

1.0

159.75

165.39

g/l

0.38

100

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

129

1231

1.04

0.17

2.4

2.6

—

(3020491) Glucose [Moles/volume] in Blood

666

1.06

0.17

1.5

1.7

6.78

6.21

mmol/l

0.76

499

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

412

0.92

0.17

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.12

0.17

2.4

5.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

329

0.91

0.17

1.4

1.2

53.66

9.25

u/ml

0.60

255

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.14

0.16

2.4

2.2

—

(3001556) Androgen free Index in Serum or Plasma

148

1.14

0.16

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

160

1538

1.04

0.16

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

1.18

0.16

1.2

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.11

0.16

1.0

1.3

—

577.53

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1695

16729

1.01

0.16

2.3

2.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

475

1.07

0.15

1.0

1.1

6.18

11.21

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

311

1.09

0.15

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

233

0.90

0.15

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

776

0.95

0.14

1.4

28.41

31.53

nmol/l

0.47

707

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

409

1.07

0.14

5.2

6.6

67.00

7738.10

u/ml

—

(3033799) Differential panel - Peritoneal fluid

201

0.89

0.14

1.4

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

887

1.04

0.14

4.6

238.43

98.70

u/ml

0.43

278

(3002079) Sodium [Moles/time] in 24 hour Urine

386

0.93

0.13

1.0

1.3

149.69

159.03

mmol/24h

0.32

386

(40768793) Breast Pathology biopsy report

201

1950

1.03

0.13

1.2

1.3

—

(1761868) Lipid panel - Serum or Plasma

3227

32314

0.99

0.13

2.7

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

166

1606

1.03

0.13

1.2

—

(3024932) HLA-DR beta [Type]

323

0.93

0.12

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.17

0.12

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

286

1.08

0.12

1.5

2.1

—

(3025130) Human papilloma virus identified in Specimen

144

1479

0.97

0.12

1.7

—

(40768446) Kidney Pathology biopsy report

364

1.07

0.12

1.9

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

126

0.87

0.12

1.5

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

171

1.11

0.11

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

268

1.08

0.11

1.5

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

239

0.92

0.11

1.2

1.1

54.46

52.59

u/ml

0.04

232

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.15

0.11

2.0

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

135

1384

0.97

0.11

3.2

3.5

121.69

532.11

u/ml

1.31

124

1266

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

143

1.11

0.11

1.1

1.0

0.03

0.13

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

669

1.04

0.10

2.0

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

228

0.92

0.10

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

191

1946

0.98

0.10

1.3

4.38

4.02

ug/l

0.17

173

1779

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

279

1.07

0.10

1.6

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

279

1.07

0.10

1.6

2.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

155

0.90

0.09

1.0

1.1

90.32

76.08

ug/l

—

131

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.06

0.09

1.0

1.5

33.92

24.60

nmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

347

3406

1.02

0.09

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

359

0.94

0.09

1.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

359

0.94

0.09

1.1

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

0.89

0.09

1.4

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

662

1.04

0.09

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.07

0.08

1.2

—

(3014271) Vancomycin [Susceptibility]

297

0.94

0.08

3.1

2.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.05

0.08

1.3

1.6

36.50

43.21

umol/l

—

(40768441) Liver Pathology biopsy report

640

0.96

0.08

1.5

—

(3045142) Bone marrow Pathology biopsy report

800

0.97

0.07

1.2

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

127

1.10

0.07

1.1

1.7

0.01

8.40

u/ml

—

109

(3008757) Leukocyte morphology finding [Identifier] in Blood

854

1.03

0.07

4.2

3.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

176

1.08

0.07

1.1

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

1.03

0.07

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.87

0.06

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

150

1522

0.98

0.06

1.2

1.1

75.36

6947.03

iu/ml

0.64

390

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

510

1.04

0.06

1.7

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

233

0.94

0.06

2.1

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

172

0.93

0.06

1.9

4.4

38.69

69.54

u/l

1.23

166

(3034426) Prothrombin time (PT)

344

1.04

0.05

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

575

0.97

0.05

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1401

13903

1.00

0.05

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

720

1.02

0.05

3.1

3.3

59.45

55.91

0.76

619

(3036071) Salmonella sp Ab [Titer] in Serum

342

0.96

0.05

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

139

1.08

0.05

1.3

1.6

78.53

121.60

ng/l

1.74

139

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

100

1.10

0.04

1.5

2.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

824

0.98

0.04

1.1

1.2

1.04

6.82

u/ml

1.51

280

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

361

0.97

0.04

2.0

93.92

175.12

ug/min

0.38

(21494890) Protein electrophoresis panel - 24 hour Urine

624

1.02

0.04

2.1

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

155

1527

1.01

0.03

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

800

0.98

0.03

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

128

0.93

0.03

4.2

2.9

1659.42

3398.57

u/l

0.43

118

(3019174) dRVVT (LA screen)

1.08

0.02

1.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

219

2197

0.99

0.02

1.5

1.4

91.44

128.25

pmol/l

0.86

212

2138

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

177

0.96

0.02

1.8

1.7

4.44

2.14

ug/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

212

1.03

0.01

1.3

1.2

—

(4034850) Laboratory test

262

2599

1.00

0.01

9.9

8.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

103

1.06

0.01

2.5

2.7

—

(3016330) Potassium [Moles/time] in 24 hour Urine

116

0.94

0.01

1.0

1.2

—

94.32

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

0.95

0.01

1.8

1.7

46.75

61.41

ng/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

145

1436

1.01

0.01

1.4

6.99

6.91

mmol/l

0.16

138

1292

(3032057) Clostridioides difficile [Presence] in Stool

153

1.04

0.01

2.3

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

173

1731

1.00

0.01

1.1

8.49

5.86

u/ml

0.41

777

(3037692) Legionella sp identified in Specimen by Organism specific culture

245

0.98

0.00

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

149

1478

1.00

0.00

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

230

2285

1.00

0.00

1.1

2.51

u/ml

0.00

133

1261

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

205

0.97

0.00

1.2

1.1

13.25

3.52

u/ml

0.69

171

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

185

0.97

0.00

1.3

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

353

1.02

0.00

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

308

1.00

0.00

2.4

2.5

—

(40758292) HTLV I+II Ab panel - Serum

159

1.00

0.00

1.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

133

0.97

0.00

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

197

1.01

0.00

1.2

260.54

302.24

pmol/l

0.37

144

(40765096) Chromosome analysis panel by Banding

211

0.99

0.00

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

400

3982

1.00

0.00

1.9

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

111

0.99

0.00

6.9

4.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

109

1.01

0.00

1.6

1.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

134

0.97

0.00

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

306

1.01

0.00

2.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

168

1.01

0.00

1.6

2.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

746

1.00

0.00

1.2

1.4

—

(21494434) Karyotype in Bone marrow

612

0.99

0.00

1.1

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.82

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.92

-0.00

1.0

—

(3008607) Semen analysis panel

0.94

-0.00

1.0

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.67

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.00

-0.00

1.2

2.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.01

-0.00

1.5

2.3

0.75

0.65

u/field

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.5

—

23.14

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.98

-0.00

1.2

1.0

—

(3001729) Color of Synovial fluid

0.93

-0.00

1.8

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.98

-0.00

1.0

1.1

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

7.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_STRABOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_STRABOTH	1.246 [1.08, 1.43]	0.002
Birth year	0.996 [0.99, 1.0]	0.356

During the follow-up period (1.1.1998 — 31.12.2019), 1429 out of 37481 females with H7_STRABOTH died.

Males

Parameter	HR [95% CI]	p-value
H7_STRABOTH	1.379 [1.19, 1.6]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1586 out of 32399 males with H7_STRABOTH died.

Mortality risk

Mortality risk for people of age

years, who have H7_STRABOTH.

N-year risk	Females	Males
1	0.161%	0.237%
5	0.805%	1.501%
10	1.72%	3.904%
15	3.304%	7.044%
20	5.955%	11.789%

Relationships between endpoints

↥

Index endpoint: H7_STRABOTH – Other strabismus

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other strabismus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints